Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Feb 19.
Published in final edited form as: J Org Chem. 2021 Dec 7;86(24):17790–17803. doi: 10.1021/acs.joc.1c02116

Silylpyrrole Oxidation En Route to Saxitoxin Congeners Including 11-Saxitoxinethanoic Acid

Doris T Y Tang 1, Jeffrey E Merit 2, T Aaron Bedell 3, J Du Bois 4
PMCID: PMC8857915  NIHMSID: NIHMS1778357  PMID: 34874731

Abstract

Saxitoxin (STX) is the archetype of a large family (>50) of architecturally distinct, bisguanidinium natural products. Among this collection of isolates, two members, 11-saxitoxinethanoic acid (11-SEA) and zetekitoxin AB (ZTX), are unique, bearing carbon substitution at C11. A desire to efficiently access these compounds has motivated the development of new tactical approaches to a late-stage C11-ketone intermediate 26, designed to enable C–C bond formation using any one of a number of possible reaction technologies. Highlights of the synthesis of 26 include a metal-free, silylpyrrole oxidative dearomatization reaction and a vinylsilane epoxidation–rearrangement cascade to generate the requisite ketone. Nucleophilic addition to 26 makes possible the preparation of unnatural C11-substituted STXs. Olefination of this ketone is also demonstrated and, when followed by a redox-neutral isomerization reaction, affords 11-SEA.

Graphical Abstract

graphic file with name nihms-1778357-f0001.jpg

1. INTRODUCTION

Bisguanidinium toxins, as exemplified by saxitoxin (STX), act as acute poisons by inhibiting the flow of ions through voltage-gated sodium ion channels (Navs).1 These unique metabolites are the products of an unusual biosynthetic pathway and comprise >50 discrete congeners.2,3 Among this family of natural products, 11-saxitoxinethanoic acid (11-SEA) and zetekitoxin AB (ZTX) are distinct as the only bisguanidinium toxins having C11 alkyl substitution (Figure 1).4,5 With an interest in preparing 11-SEA, ZTX, and derivatives thereof through a divergent synthesis, we have investigated different strategies for generating functionally disparate C11-structures. This work has culminated in the identification of a novel silyl epoxide rearrangement for the preparation of a C11-ketone intermediate, which enables access to 11-SEA. The chemistry outlined in this report makes available a number of unique bisguanidinium derivatives and is driving subsequent efforts to explore Nav physiology.1b,2,6

Figure 1.

Figure 1.

STX and naturally occurring C11-substituted derivatives.

2. RESULTS AND DISCUSSION

In our previously reported synthesis of 11-SEA, a Stille cross-coupling reaction with an intermediate iodoenaminone formed the requisite C11 carbon–carbon bond (Scheme 1).7,8 Difficulties associated with preparing the stannane reagent and the capriciousness of the Pd-catalyzed coupling reaction reduced the overall efficiency of this route. Alternative cross-coupling technologies to prepare C11 derivatives were similarly ineffective, and a synthesis of ZTX using such chemistry was deemed unworkable. These findings motivated our efforts to develop an alternative set of tactics for assembling 11-SEA and other C11-substituted structures.

Scheme 1.

Scheme 1.

Cross-Coupling Step to Install C11 Substitution in First-Generation Synthesis of 11-SEAa

aR = SitBuPh2

Two strategies for introducing a carbon-substituent group at the C11 position on the tricyclic core of STX were envisioned: (1) cross-coupling with an appropriate vinyl halide 1 and (2) nucleophilic addition to ketone 2 (Figure 2). These approaches present a complementary set of reaction conditions for C–C bond formation. Implementing both plans would thus facilitate access to a large number of STX derivatives to support toxin structure–activity relationship studies.

Figure 2.

Figure 2.

Two strategies for C11-C–C bond formation.

In considering alternative means for assembling C11-STX derivatives including 11-SEA, we were drawn initially to vinyl bromide 1 as a cross-coupling partner. In principle, this compound could be derived through a multistep route from 3-bromo-N-triisopropylsilyl pyrrole 4 (Scheme 2). Pyrrole, a π-electron-rich heterocycle, is intrinsically nucleophilic at the 2- and 5-positions; however, bromination at the 3-position is favored on the N-SiiPr3 derivative.9 Desilylation of 4 was accomplished using nBu4NF, revealing the corresponding N–H pyrrole (Scheme 2). This material was used immediately due to its susceptibility to oxidation. Deprotonation of the N–H pyrrole with potassium tert-butoxide and addition to CO2 generated pyrrole carboxylic acid 5. As this compound was also prone to decomposition, a subsequent condensation reaction with l-serine methyl ester was telescoped to afford 6 (53% yield over four steps from 4). Low-temperature reduction of methyl ester 6 to the corresponding aldehyde using iBu2A1H occurred without incident. Allyl imine formation and Pictet–Spengler cyclization were then effected in a one-flask procedure, which generated a single isomeric product 7 in a respectable 59% yield.10 Unfortunately, 1H NMR of this material clearly indicated that the Br substituent was incorrectly placed at C12 (SEA numbering). This result is perhaps unsurprising given the ortho/para-directing nature of the Br group.

Scheme 2.

Scheme 2.

Pictet–Spengler Cyclization of Bromopyrrole 6 Yields the Undesired Regioisomer (Carbon Numbering is Based on 11-SEA)a

aReagents and conditions: (a) nBu4NF, tetrahydrofuran (THF); (b) KOlBu, THF/Et2O; then CO2; (c) (COCl)2, cat. N,N-dimethylformamide (DMF), THF, 0 °C; then l-serine methyl ester, aqueous NaHCO3 (d) tBuPh2SiCl, imidazole, DMF, 53% (4 steps); (e) (1) iBu2AlH, CH2Cl2, −90 °C, (2) allylamine, then BF3·OEt2 59%, >20:1 dr (2 steps).

Unable to access the desired C11-brominated bicycle 8, an analogous R3Si-pyrrole intermediate was targeted with the expectation that the silyl substituent would sterically and electronically bias formation of the C11-isomer in the cyclization event.11 To assess whether the choice of silyl group would influence regioselectivity in the Pictet–Spengler reaction, different C3-silyl pyrroles were generated through lithium–halogen exchange of bromopyrrole 4 followed by trapping with an appropriate silyl chloride (Scheme 3). Formation of pyrrole N-carboxylic acid 10 was achieved in two steps through N-SiiPr3 deprotection with KF in MeOH–conditions that did not cleave the C-silyl group–followed by carboxylation with CO2. As with 3-bromo-1H-pyrrole and the carboxylated intermediate 5, the analogous silyl derivatives were processed immediately to urea 11.

Scheme 3.

Scheme 3.

Synthesis of Urea 11a

aReagents and conditions: (a) nBu4NF, THF, −78 °C; then R3SiCl; (b) KF, MeOH; (c) KOtBu, THF/Et2O; then CO2; (d) (COCl)2 cat. DMF, THF, 0 °C; then l-serine methyl ester, aqueous NaHCO3, 43% (4 steps); (e) tBuPh2SiCl, imidazole, DMF, 94%. R = Me3Si-, tBuMe2Si-, PhMe2Si-, iPr3Si-.

Conversion of each of the four silylated intermediates (11) to the corresponding bicyclic product was accomplished through ester reduction and BF3·OEt2-promoted Pictet–Spengler reaction (Table l). The desired C11-isomer 12 was favored irrespective of the choice of silyl group, though the best results were obtained with the sterically largest silyl derivatives (entries 2 and 4). A small amount of the protodesilylated material (i.e., R = H) was obtained in most cases as well. From these results, it appears that both steric and hyperconjugative (i.e., β-silyl cation) effects bias production of the C11-isomer 12. As in the synthesis of Br-pyrrole 7, the Pictet–Spengler reaction furnished bicyclic urea 12 as the trans stereoisomer with >20:1 diastereoselectivity.

Table 1.

Influence of the Silyl Group on Pictet–Spengler Regioselectivity

graphic file with name nihms-1778357-t0036.jpg
Entry R 12(%)a 13(%) R = H (%)
1 Me3Si 32 11 10
2 tBuMe2Si 53 3 13
3 PhMe2Si 43 11
4 iPr3Si 50 3
a

Reported yields are combined for the two-step process and based on isolated material.

Although the iPr3Si derivative (Table 1, entry 4) was the most selective for generating 12 over the two-step sequence, we opted to advance the tBuMe2Si and PhMe2Si products (entries 2 and 3, respectively), uncertain as to which silyl intermediate would perform best in subsequent transformations. Deprotection of the allylamine in 12 was accomplished using catalytic Pd(PPh3)4 and 1,3-dimethylbarbituric acid (Scheme 4), and the resulting primary amine was smoothly converted to an isothiourea (95% yield, 2 steps).12 Subsequent O-ethylation of the cyclic urea furnished 14. Both isourea moieties in 14 were displaced with ammonia to give the bisguanidine, and finally, acylation of the 6-membered ring guanidine yielded Troc guanidine 16. The choice of C11-silyl substituent was inconsequential to the performance of this chemistry.7,13

Scheme 4.

Scheme 4.

Synthesis of Troc Guanidine 16a

aReagents and conditions: (a) Pd(PPh3)4, 1,3-dimethylbarbituric acid, CH2Cl2; then TcesN=C(SMe)Cl, Na2CO3, 95%; (b) EtOTf, 2,4,6-tri-t-butylpyrimidine, CH2Cl2, 38 °C, 84%; (c) NH3, NH4OAc, MeOH, 75 °C, 68%; (d) Troc benzimidazolium triflate 15, 1,2-dichloroethane, 50 °C, 74%. Similar yields were obtained for C11 tBuMe2Si substrates. Tces = −S(O)2OCH2CCl3; Troc = −C(O)-OCH2CCl3.

Assembling the tricyclic core of the bisguanidinium toxins from intermediate 16 requires forging a C–N bond between N9 and C4 (SEA numbering, Scheme 5). In our prior synthesis of gonyautoxin 2/3,13 this step (1819) was accomplished through a novel [Rh2(esp)2]-catalyzed oxidative dearomatization reaction. The modest performance of this reaction, however, did not translate to the silylated material 16, as <20% of desired product 17 was obtained with no recovered starting material. Upon screening alternative conditions to promote this reaction, we noted a marked improvement in the reaction outcome when the Rh catalyst was omitted. By simply combining PhI(OAc)2, MgO, and 16, the tricyclic bisguanidine 17 was obtained in 55% yield (Table 2, entry 1).14

Scheme 5.

Scheme 5.

Cyclic Guanidine Formation through Pyrrole Oxidation

Table 2.

Metal-free Pyrrole Oxidative Dearomatization

graphic file with name nihms-1778357-t0037.jpg
entry R R conditions % yielda
1 SiMe2Ph SitBuPh2 PhI(OAc)2, MgO 55
2 H SitBuMc2 PhI(OAc)2, MgO 43
3 H SitBuMe2 PhI(OAc)2, Na2CO3 37
4 H SitBuMe2 PhI(OPiv)2, MgO 43
5 H SitBuMe2 PhI(OPiv)2, Na2CO3 47
6 H SitBuMe2 DMP, Na2CO3 89
7 SiMe 2 Ph Si t BuPh 2 DMP, Na 2 CO 3 74
a

% yield is based on isolated material. DMP = Dess–Martin periodinane.

In light of our discovery of a Rh-free pyrrole dearomatization reaction, further optimization of this critical step was pursued (Table 2). These experiments were performed using pyrrole 18 (i.e., R = H) given the ready availability of this compound. Different combinations of hypervalent iodine(III) oxidants and inorganic bases were tested to little effect (entries 2–5). Switching to Dess–Martin periodinane, however, resulted in a substantial improvement in reaction performance, affording the desired tricycle in 89% yield (entry 6). Applying these same conditions to silylpyrrole 16 generated the product 17 in 74% yield (entry 7). This finding offers a convenient solution to a critical reaction step and enables multigram production of the tricyclic core of SEA and related toxins.

Relying on prior work from our lab, transforming N,O-acetal 17 to the corresponding allylic alcohol 21 proved straightforward (Scheme 6).7,15 An unusual Mislow–Evans [2,3]-rearrangement to transpose the C11, C12-alkene highlights this sequence.16 Isolation of 21 accomplishes the intended goal of introducing a C11-substituent that can enable C–C bond formation at this site. In principle, silyl–halogen exchange could deliver a vinyl halide suitable for cross-coupling. Alternatively, oxidation of the vinylsilane would afford the C11-ketone. The potential versatility of intermediate 21 is a defining feature of this approach to the bisguanidinium natural products.

Scheme 6.

Scheme 6.

Mislow–Evans Rearrangement Gives C12-Alcohol 21a

aReagents and conditions: (a) PhSH, BF3·OEt2, CH2Cl2, 75%; (b) m-CPBA, CH2Cl2, 94%; (c) NaSPh, Cl3CCH2OH, 80 °C, 88%. Similar yields were obtained for R = tBuMe2Si substrates.

Attempts to promote ipso-halogen substitution of either the C11-tBuMe2Si or PhMe2Si group have been unsuccessful thus far.17 As such, our efforts turned to formation of a C11 hydroxyketone, the expected product of a sequential epoxidation/rearrangement cascade (Figure 3). In the event, treatment of tBuMe2Si-21 with m-CPBA furnished α-silyl ketone 24; this product, which is obtained as a single diastereomer, results from opening of the putative epoxide and [1,2]-silyl migration. In striking contrast, subjecting PhMe2Si-21 to the same reaction conditions yielded ketone 26 quantitatively. While somewhat unexpected, these results are consistent with Malacria’s observations on the rearrangement of silyl allylic epoxides.18,19

Figure 3.

Figure 3.

C11-Silyl substituent dictates the product outcome from m-CPBA reaction. (A) Silyl-[1,2]-shift affords α-silyl ketone 24. (B,C) Putative mechanisms for C11-ketone 26 formation involving silyl group elimination or Brook rearrangement. R’ = SitBuPh2.

Evident differences in the reactivity of ketones 24 and 26 were revealed upon attempts to isolate each product. The C10-tBuMe2Si material 24 was easily obtained following chromatography on silica gel, whereas 26 readily decomposed under such conditions. Addition of nucleophiles (e.g., MeMgBr, Cp2TiMe2, and Zn-enolate) to ketone 24 were fruitless, presumably owing to the steric bulk of the tBuMe2Si group on the re-face of the tricycle. All attempts to cleave the silyl substituent using different fluoride sources (nBu4NF, nBu4N-(Ph3SiF2), and KF) or Brønsted acid conditions (CF3CO2H, HBF4, and PPTS) were equally unsuccessful. Fortunately, despite the instability of ketone 26 to chromatography, subsequent experiments with this material were possible, as its preparation from 21 was quantitative. However, addition of conventional nucleophiles such as MeMgBr to this compound was mired by low product yields and the formation of a byproduct 29 resulting from enolization at C12 and β-elimination of the N9-guanidine (Table 3, entry 1). Attempts to temper the kinetic basicity of the nucleophile using Ce and Zn additives resulted in marginal improvements in the production of diol 28 (entries 2 and 3). Of all the organometallic reagents tested, the reaction of allylindium bromide was distinguished, providing the corresponding allylic alcohol in 47% (entry 4).20 Even nonbasic conditions (i.e., the combination of silyl ketene acetal nucleophiles and Lewis acid catalysts) afforded only modest amounts of the desired products (entry 7).

Table 3.

Nucleophilic Addition to C11-Ketone 26

graphic file with name nihms-1778357-t0038.jpg
entry nucleophile conditions % yielda
1 MeMgBr Et2O 10
2 MeMgBr CeCl3, THF 20
3 AllylMgBr ZnCl2, THF 35
4 AllylBr In, THF 47
5 BrCH2CO2Et Zn, THF
6 MeOC(OSiMe3)=CMe2 Sc(OTf)3, CH2Cl2
7 MeOC(OSiMe3)=CMe2 TiCl4, CH2Cl2 20
a

% yield is based on isolated material.

In searching for a means to efficiently install a C11–C14 bond in 26, methods for ketone olefination were also examined. Given the evident sensitivity of 26 to base, it was unsurprising that only decomposition ensued upon treatment of this material with simple Wittig reagents (e.g., Ph3P=CH2). Other olefination methods using sulfone reagents (eq 1) and different bases (e.g., LiN(SiMe3)2, NaOtBu, and DBU) were equally unproductive. Organometallic methods for ketone methylenation, including Cp2TiMe2 and the Tebbe reagent, also failed to deliver the desired product. A modicum of success was realized when 26 was exposed to the lithium salt of the triethyl phosphonoacetate anion (Table 4, entry 1). In this case, ~30% yield of the α,β-unsaturated ester was obtained as a 2:1 mixture of alkene isomers. Switching to the equivalent potassium phosphonoacetate salt afforded only trace product (entry 2). The use of triethylamine and lithium chloride, conditions that have proven successful with base-sensitive ketone substrates, decomposed the starting ketone (entry 3).21 Application of the Still–Gennari modification gave a 2:3 Z/E product ratio and was poor yielding (entry 4).22 A protocol employing NaH with triethyl phosphonoacetate at −40 °C was ultimately selected to advance material through this step (entry 5).23

2. (1)

Table 4.

Olefination of C11-Ketone 26

graphic file with name nihms-1778357-t0039.jpg
entry R conditions % yielda Z/E ratio
1 OEt LiOtBu, THF 29 2:1
2 OEt KOtBu, THF <5
3 OEt NEt3, LiCl, MeCN
4 OCH2CF3 KHMDS, 18-C-6, THF 10 2:3
5 OEt NaH, THF, −40 °C 37 3:2
a

% yield is based on isolated material.

With access to 30 and 31, it is possible to complete a formal synthesis of 11-SEA by oxidizing the secondary alcohol at C12 and reducing the C11–C14 alkene. In an initial attempt to effect the former reaction, treatment of the Z/E mixture of alcohols with Dess–Martin periodinane proved successful and delivered ketone 32 in 76% yield (Figure 4). Interestingly, the product of this reaction was obtained exclusively as the E-isomer in spite of the fact that the starting alcohol was a near 1:1 mixture of olefins. A putative mechanism to account for this result is depicted in Figure 4. As either the Z- or E-isomer, 30 or 31, can be converted to 11-SEA, the unanticipated isomerization reaction was inconsequential.

Figure 4.

Figure 4.

Alcohol oxidation of an isomeric mixture of 30/31 affords a single product.

Selective reduction of the C11–C14 olefin in 32 can be accomplished without cleaving the Troc or Tces guanidine protecting groups (Scheme 7). Using Crabtree’s Ir catalyst with 500 psi of H2, the saturated product 33 was obtained as a 2.5:1 mixture of C11 isomers.24 In nature, 11-SEA occurs as a 3:1 diastereomeric mix, as the C11 center is intrinsically labile.4 The saturated ester 33 intercepts our previously published route to the natural product, necessitating only three additional steps to complete the synthesis.7

Scheme 7.

Scheme 7.

Ir-Catalyzed Alkene Hydrogenationa

aReagents and conditions: (a) H2 (500 psi), 30 mol% [Ir(cod)-(PCy3)(py)]PF6, B(OiPr)3, CH2Cl2, 35%; (b) nBu4NF, AcOH, THF, 73%.

Although successful conversion of alcohols 30/31 to 33 was achieved through an oxidation/reduction sequence, a more appealing process would furnish 33 in a single-step, redox isomerization reaction.25 The fortuitous observation that Dess–Martin periodinane promoted oxidation and isomerization of 30/31 led us to consider using a mild base to facilitate production of 33 (Table 5). Following a brief screening of different acetate salts, we found that low-temperature treatment of 30 with nBu4NOAc afforded approximately equal portions of ketone 33 and allylic alcohol 35 (entry 1). Additional experimentation revealed that redox isomerization of 30 occurred in a THF solution of nBuN4F buffered with AcOH, conditions that yielded a significantly reduced amount of the undesired allylic alcohol 35. In addition, this protocol also cleaved the C13 tBuPh2Si ether to furnish 34, an added bonus as this transformation represents the antepenultimate step in our synthesis of 11-SEA. Two final maneuvers from 34—(1) installation of the C13-carbamate and (2) hydrogenolytic removal of the Tces and Troc groups with concomitant hydrolysis of the ethyl ester—afforded 11-SEA as a 3:1 mixture of stereoisomers (Scheme 8).4,7,8

Table 5.

Base-Promoted Isomerization of Z-Alkene 30

graphic file with name nihms-1778357-t0040.jpg
entry Conditions R′ % yielda 33/35 ratio
1 nBu4NOAc, −78 °C → rt SitBuPh2 50 1.2:1
2 nBu4NF, AcOH, −78 → 0 °C H 73 9:1b
a

% yield is based on isolated material.

b

Ketone 34 is obtained from this reaction.

Scheme 8.

Scheme 8.

Completed Synthesis of 11-SEAa

aReagents and conditions: (a) 1,1′-carbonyldiimidazole, THF; then 0.5 M NH3 in THF, 54%; (b) 1 atm H2, PdCl2, CF3CO2H, MeOH/H2O; then 1.0 M aqueous HCl.

As an addendum to the discussion above, it appears that only the Z-isomer, 30, is predisposed to the redox isomerization reaction. Treatment of E-isomer 31 with nBuN4F/AcOH results exclusively in deprotection of the C13-silyl ether. We speculate that hydrogen bonding between the ester carbonyl and the C12 alcohol in 30 predisposes the conformation of the C12-H for facile deprotonation. Given the relative rigidity of the tricyclic bisguanidinium skeleton, the structural subtleties responsible for the success or failure of this transformation are striking.

3. CONCLUSIONS

We have capitalized on the versatility of hydroxyketone 26 to complete the synthesis of 11-SEA in 16 steps from l-serine methyl ester. Importantly, this same intermediate enables introduction of disparate C11-alkyl substituents through nucleophilic addition or olefination. The route to 26 is punctuated by a number of novel transformations including regio- and diastereoselective Pictet–Spengler cyclization, Dess–Martin periodinane-promoted silylpyrrole dearomatization, and silyl olefin epoxidation. The chemistry described herein facilitates access to new STX derivatives and propels efforts to develop high-precision small molecule tools for investigating sodium channel physiology.

4. EXPERIMENTAL SECTION

General.

All reagents were obtained commercially unless otherwise noted. Reactions were performed using oven-dried glassware under an atmosphere of nitrogen. Air- and moisture-sensitive liquids were transferred via syringe or a stainless-steel cannula. Organic solutions were concentrated under reduced pressure (~15 Torr) by rotary evaporation. Dichloromethane (CH2Cl2), THF, DMF, and acetonitrile (MeCN) were passed through two columns of activated alumina immediately prior to use. Methanol was distilled over sodium methoxide. Dry ethanol was used from a Sure/Seal bottle. Triethylamine, pyridine, and pyrrolidine were distilled over calcium hydride. (Diacetoxyiodo)benzene was recrystallized from 5 M acetic acid,26 and m-CPBA was purified according to the method of Aggarwal et al.27 Dess–Martin periodinane (1,1,1-tris(acetyloxy)-1,1-dihydro-1,2-benziodoxol-3-(1H)-one) was purchased from Millipore Sigma or Combi-Blocks, Inc. and used as received.

Product purification was accomplished through forced flow chromatography on SiliCycle ultrapure silica gel (40–63 μm). Compounds purified by chromatography were typically applied to the adsorbent bed using the indicated solvent conditions with a minimum amount of added dichloromethane as needed for solubility. Thin-layer chromatography (TLC) was performed on EM Science silica gel 60 F254 plates (250 μm). Visualization of the developed chromatogram was accomplished using fluorescence quenching or by staining with ethanolic anisaldehyde, aqueous potassium permanganate (KMnO4), or ceric ammonium molybdate solution.

Nuclear magnetic resonance (NMR) spectra were acquired on either a Varian Inova spectrometer operating at 400, 500, or 600 MHz and 100, 125, or 150 MHz for 1H and 13C, respectively, or a Varian Mercury spectrometer operating at 400 and 100 MHz for 1H and 13C, respectively. Spectra were referenced internally according to residual solvent signals and were recorded at room temperature unless otherwise noted. Data for 1H NMR are recorded as follows: chemical shift (δ, ppm), multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; and br, broad), coupling constant (Hz), and integration. Data for 13C NMR are reported in terms of chemical shift (δ, ppm). Infrared (IR) spectra were recorded as thin films using NaCl plates on a Thermo Nicolet iS5 FT-IR spectrometer and are reported in frequency of absorption. High-resolution mass spectra were obtained from the Vincent Coates Foundation Mass Spectrometry Laboratory at Stanford University. Samples were analyzed by LC/electrospray ionization mass spectrometry (ESI-MS) using either positive or negative ionization modes (as indicated) on one of two instruments: (1) a Waters Acquity UPLC and Thermo Fisher Exactive mass spectrometer scanning m/z 50–2000, the LC mobile phase being acetonitrile with 0.1% formic acid, or (2) a Shimadzu 2020 ESI–LCMS instrument.

4.

A solution of 3-bromo-1-triisopropylsilyl pyrrole 428 (15.4 g, 51 mmol) in 150 mL of THF was cooled to −78 °C, and n-BuLi (60 mL of a 1.66 M solution in hexanes, 100 mmol, 2.0 equiv) was added while maintaining the internal temperature below −72 °C. After stirring at −78 °C for 5 min, PhMe2SiCl (17 mL, 101 mmol, 2.0 equiv) was added dropwise. The mixture was warmed to room temperature over 2 h. Following this time, the solution was cooled to 0 °C and diluted with 150 mL of H2O. The contents were transferred to a separatory funnel with 100 mL of Et2O, and the organic phase was collected. The aqueous phase was extracted with 2 × 150 mL of Et2O. The combined organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure to give the desired silylated pyrrole, which was used immediately and without further purification.

To a solution of the unpurified pyrrole (51 mmol) in 200 mL of MeOH was added KF (3.0 g, 52 mmol, 1.0 equiv) in a single portion. The solution was stirred at room temperature for 15 h. Following this time, the reaction mixture was concentrated under reduced pressure and the oily residue was partitioned between 150 mL of H2O and 100 mL of Et2O. The mixture was transferred to a separatory funnel and the organic phase was collected. The aqueous phase was extracted with 2 × 100 mL of Et2O. The combined organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure. The unpurified material was dissolved in 20 mL of Et2O and added to an ice-cold solution of KOtBu (6.0 g, 53.5 mmol, 1.05 equiv) in 150 mL of a 1:1 mixture of THF and Et2O. The solution was warmed to room temperature and stirred for 20 min, after which time the mixture was sparged with CO2 gas for 75 min. The reaction mixture was diluted with 100 mL of H2O and transferred to a separatory funnel. The aqueous phase was collected and acidified to pH 1 with 1.0 M aqueous HC1 (~60 mL) and then extracted with 3 × 100 mL of Et2O. The combined organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure to afford the desired pyrrole carboxylic acid 10 (7.3 g, 58% over three steps). The material was determined to be sufficiently pure by 1H NMR analysis for use in the subsequent step. 1H NMR (400 MHz, CDCl3): δ 7.56−7.52 (m, 2H), 7.38−7.34 (m, 4H), 7.34−7.32 (m, 1H), 6.33 (dd, 1H, J = 3.2, 1.7 Hz), 0.49 (s, 6H) ppm.

4.

To an ice-cold solution of the pyrrole carboxylic acid 10 (7.3 g, 30 mmol) in 50 mL of THF, DMF (0.25 mL, 3.2 mmol, 0.1 equiv) and oxalyl chloride (2.6 mL, 30 mmol) were added sequentially. Vigorous gas evolution was observed upon addition of oxalyl chloride. The reaction mixture was stirred at 0 °C until all bubbling ceased (approximately 30 min), and then, a solution of l-serine methyl ester hydrochloride (4.78 g, 31 mmol) in 100 mL of saturated aqueous NaHCO3 was added in a single portion. The biphasic mixture was stirred vigorously at 0 °C for 15 min, then warmed to room temperature, and stirred for 15 h. The mixture was transferred to a separatory funnel and the organic phase was collected. The aqueous phase was extracted with 3 × 100 mL of Et2O. The combined organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure. Purification of the isolated material by chromatography on silica gel (gradient elution: 3:1 → 3:2 hexanes/EtOAc) afforded S1 as a clear oil (7.6 g, 74%; 43% from 4). TLC Rf = 0.42 (1:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.56−7.52 (m, 2H), 7.37−7.29 (m, 5H), 6.65 (d, 1H, J = 7.1 Hz), 6.33 (dd, 1H, J = 3.0, 1.5 Hz), 4.73−4.68 (m, 1H), 4.10−4.03 (m, 1H), 4.00−3.93 (m, 1H), 3.78 (s, 3H), 2.78 (t, 1H, J = 6.0 Hz), 0.49 (s, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3): δ 170.9, 150.7, 138.6, 133.9, 129.1, 127.9, 125.0, 120.6, 119.8, 117.2, 63.0, 55.7, 53.1, −1.8 ppm; IR (thin film) ν: 3368, 2954, 1744, 1681, 1542, 1479, 1379, 1342, 1220 cm−1; HRMS (ES+) calcd for C17H23N2O4Si+, 347.1422 [M + H]+; found, 347.1420.

4.

To a solution of alcohol S1 (3.53 g, 10.2 mmol) in 14 mL of DMF were added sequentially imidazole (904 mg, 13.3 mmol, 1.3 equiv) and tBuPh2SiCl (2.65 mL, 10.2 mmol). The reaction mixture was stirred for 12 h and then diluted with 150 mL of H2O and 100 mL of Et2O. The contents were transferred to a separatory funnel, and the organic phase was collected and washed with 2 × 100 mL of H2O. The ethereal extract was dried over MgSO4, filtered, and concentrated under reduced pressure to an oily residue. Purification of this material by chromatography on silica gel (10:1 hexanes/EtOAc) afforded 11 as a clear oil (5.6 g, 94%). TLC Rf = 0.29 (9:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.62−7.55 (m, 6H), 7.47−7.30 (m, 9H), 7.26−7.25 (m, 1H), 7.23 (dd, 1H, J = 3.0, 2.0 Hz), 6.42 (d, 1H, J = 8.1 Hz), 6.37 (dd, 1H, J = 3.0, 1.5 Hz), 4.71 (dt, 1H, J = 8.0, 2.8 Hz), 4.22 (dd, 1H, J = 10.7, 3.2 Hz), 4.01 (dd, 1H, J = 10.7, 3.2 Hz), 3.81 (s, 3H), 1.06 (s, 9H), 0.52 (s, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3): δ 170.7, 150.1, 138.7, 135.5, 135.4, 133.9, 132.6, 132.5, 130.1, 129.1, 127.96, 127.91, 127.87, 124.9, 120.3, 119.6, 117.1, 64.2, 55.4, 52.8, 26.8, 19.3, −1.8 ppm; IR (thin film) ν: 3360, 3070, 2954, 2858, 1749, 1712, 1508, 1475, 1428, 1250, 1113 cm−1.

4.

To a −90 °C solution of 11 (12.1 g, 20.7 mmol) in 210 mL of CH2Cl2 was added iBu2AlH (27.6 mL of a 1.50 M solution in toluene, 41.4 mmol, 2.0 equiv) dropwise over 40 min. The reaction mixture was stirred at −90 °C for an additional 15 min and then quenched at this temperature by the slow addition of 20 mL of EtOAc. The contents were poured into an Erlenmeyer flask containing 210 mL of 1.0 M aqueous sodium potassium tartrate and 180 mL of EtOAc and stirred vigorously for 3 h. Following this time, the contents were transferred to a separatory funnel. The organic phase was collected, and the aqueous layer was extracted with 2 × 100 mL of EtOAc. The combined organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure to a pale yellow oil. This material was used immediately and without additional purification to avoid potential loss of optical purity.

To an ice-cold solution of unpurified aldehyde (20.7 mmol) in 210 mL of CH2Cl2 was added allylamine (2.3 mL, 30.7 mmol, 1.5 equiv). The mixture was warmed to room temperature over 20 min and then cooled to −78 °C. Neat BF3·OEt2 (9 mL, 71.7 mmol, 3.5 equiv) was added dropwise over 10 min to this solution. The mixture was stirred at −78 °C for 20 min and slowly warmed to room temperature over a 90 min period. The reaction was quenched by the addition of 200 mL of saturated aqueous NaHCO3, stirred vigorously for 12 h, and transferred to a separatory funnel. The organic phase was collected, and the aqueous layer was extracted with 3 × 100 mL of EtOAc. The combined organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure to a brown oil. Purification of this material by chromatography on silica gel (gradient elution: 2:1 → 1:1 hexanes/EtOAc) afforded 12 as a white foam (5.3 g, 43% over 2 steps). TLC Rf = 0.27 (1:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.63−7.54 (m, 6H), 7.45−7.30 (m, 10H), 6.16−6.14 (m, 1H), 6.12 (d, 1H, J = 3.1 Hz), 5.89−5.78 (m, 1H), 5.21−5.09 (m, 2H), 3.94 (d, 1H, J = 3.6 Hz), 3.75−3.69 (m, 1H), 3.61−3.57 (m, 2H), 3.32−3.18 (m, 2H), 1.03 (s, 9H), 0.51 (s, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3): δ 149.5, 138.7, 136.3, 135.6, 134.0, 132.74, 132.69, 130.3, 130.0, 129.1, 127.89, 127.86, 127.84, 124.7, 118.7, 116.6, 114.9, 64.5, 58.4, 49.7, 49.5, 26.8, 19.2, −1.78, −1.83 ppm; IR (thin film) ν: 3241, 3122, 3070, 2955, 2931, 1718, 1428, 1249, 1113 cm−1; HRMS (ES+): calcd for C35H44N3O2Si2+, 594.2967 [M + H]+; found, 594.2982.

4.

Amine 12 (3.1 g, 5.2 mmol), 1,3-dimethylbarbituric acid (2.4 g, 15.6 mmol, 3.0 equiv), and Pd(PPh3)4 (129 mg, 0.11 mmol, 0.02 equiv) were combined in a 250 mL round-bottomed flask, and the flask was flushed with N2 for several minutes. To the reaction vessel was added 52 mL of degassed CH2Cl2 (3× freeze/pump/thaw cycle). The orange solution was stirred for 13 h, following which time 50 mL of a 1 M aqueous solution of Na2CO3 and TcesN=C(SMe)Cl29 (1.69 g, 5.3 mmol, 1.02 equiv) was added sequentially. The biphasic mixture was stirred for 20 min, then diluted with 50 mL of EtOAc, and transferred to a separatory funnel. The organic phase was collected, and the aqueous layer was extracted with 2 × 50 mL of EtOAc. The combined organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure to an orange oil. Purification of this material by chromatography on silica gel (gradient elution: 4:1 → 3:1 hexanes/EtOAc) afforded isothiourea S2 as a yellow foam (4.2 g, 95%). TLC Rf = 0.36 (2:1 hexanes/EtOAc; 1H NMR (400 MHz, CDCl3): δ 8.13 (d, 1H, J = 9.3 Hz), 7.62−7.57 (m, 2H), 7.57−7.52 (m, 4H), 7.47−7.30 (m, 10H), 6.33 (dd, 1H, J = 1.6, 0.8 Hz), 5.71 (br s, 1H), 5.25−5.18 (m, 1H), 4.63 (s, 2H), 3.80–3.74 (m, 1H), 3.67 (dd, 1H, J = 10.9, 6.0 Hz), 3.54 (dd, 1H, J = 10.9, 6.9 Hz), 2.48 (s, 3H), 1.04 (s, 9H), 0.50 (s, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3): δ 170.5, 148.6, 138.0, 135.5, 134.0, 132.2, 132.1, 130.26, 130.25, 129.3, 128.06, 128.05, 127.96, 125.8, 120.2, 116.9, 93.7, 78.6, 63.3, 58.0, 47.9, 26.8, 19.2, 14.7, −1.86, −1.91 ppm; IR (thin film) ν: 3361, 2955, 2858, 1717, 1559, 1428, 1351, 1351, 1165, 1113 cm−1.

4.

To a solution of S2 (5.56 g, 6.63 mmol) and 2,4,6-tri-t-butylpyrimidine (1.65 g, 6.63 mmol) in 6.5 mL of CH2Cl2 was added ethyl trifluoromethanesulfonate (2.2 mL, 17 mmol, 2.6 equiv). The reaction mixture was stirred at 38 °C for 30 h. Following this time, the reaction was cooled to room temperature and quenched by the addition of 100 mL of saturated aqueous NaHCO3. The biphasic mixture was stirred vigorously for 12 h, diluted with 25 mL of EtOAc, and transferred to a separatory funnel. The organic layer was collected, and the aqueous phase was extracted with 3 × 25 mL of EtOAc. The combined organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure to a brown oil. Purification of this material by chromatography on silica gel (gradient elution: 1:0 → 4:1 hexanes/EtOAc) afforded isourea 14 as a pale yellow foam (4.84 g, 84%). TLC Rf = 0.41 (4:1 hexanes/EtOAc); 1H NMR (500 MHz, CDCl3): δ 8.08 (d, 1H, J = 8.8 Hz), 7.67−7.64 (m, 2H), 7.62−7.57 (m, 4H), 7.47−7.36 (m, 7H), 7.31−7.27 (m, 2H), 7.07 (d, 1H, J = 1.5 Hz), 6.40−6.39 (m, 1H), 5.40 (dd, 1H, J = 9.0, 4.1 Hz), 4.64 (s, 2H), 4.37−4.23 (m, 2H), 4.02 (quint, 1H, J = 7.6, 3.7 Hz), 3.76 (dd, 1H, J = 10.3, 3.9 Hz), 3.29 (dd, 1H, J = 10.6, 8.0 Hz), 2.51 (s, 3H), 1.37 (t, 3H, J = 7.1 Hz), 1.04 (s, 9H), 0.53 (d, 6H, 1.6 Hz) ppm; 13C{1H} NMR (125 MHz, CDCl3): δ 170.6, 146.7, 138.5, 135.61, 135.57, 134.0, 132.9, 132.8, 129.9, 129.8, 129.2, 127.91, 127.85, 127.7, 126.6, 123.2, 118.6, 115.7, 93.8, 78.5, 63.5, 63.0, 61.1, 48.1, 26.8, 19.3, 14.7, 14.2, −1.6, −1.7 ppm; IR (thin film) ν: 3288, 3070, 2956, 2931, 2858, 1668, 1572, 1479, 1335, 1164, 1113 cm−1; HRMS (ES+): calcd for C38H48Cl3N4O5S2Si2+, 865.1665 [M + H]+; found, 865.1676.

4.

A 100 mL thick-walled tube containing a magnetic stir bar was charged with 14 (4.84 g, 5.59 mmol), NH4OAc (2.2 g, 28.5 mmol, 5.1 equiv), and NH3 (28 mL of a 2.0 M solution in MeOH, 56 mmol, 10 equiv). The vessel was sealed with a Teflon screw cap and the contents heated at 75 °C for 24 h. The reaction mixture was cooled to room temperature, transferred to a collection flask, and concentrated under reduced pressure. Purification of the isolated material by chromatography on silica gel (gradient elution: 1:1:0.01 hexanes/EtOAc/AcOH, then 14:1:0.01 → 12:1:0.01 CH2Cl2/MeOH/AcOH) afforded bisguanidine S3·HOAc as a white solid. In a separatory funnel, S3·HOAc was partitioned between 25 mL of Et2O and 25 mL of 1.0 M NaOH. The organic phase was collected, and the aqueous layer was extracted with 2 × 25 mL of Et2O. The combined organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure to yield S3 as a white foam (3.05 g, 68%). TLC Rf = 0.4 (10:1:0.01 CH2Cl2/MeOH/AcOH); 1H NMR (400 MHz, CD3OD, S3·HOAc): δ 7.60−7.46 (m, 6H), 7.46−7.29 (m, 10H), 6.51−6.49 (m, 1H), 5.43 (br s, 1H), 4.62 (s, 2H), 3.95−3.90 (m, 1H), 3.72 (dd, 1H, J = 11.1, 4.1 Hz), 3.64 (dd, 1H, J = 11.1, 5.3 Hz), 1.92 (s, 3H), 0.90 (s, 9H), 0.49 (s, 6H) ppm; 13C{1H} NMR (100 MHz, CD3OD, S3·HOAc): δ 179.8, 157.5, 151.8, 138.5, 136.7, 134.9, 133.5, 133.3, 131.14, 131.11, 130.4, 129.6, 129.0, 125.1, 124.8, 118.3, 95.6, 79.3, 65.6, 57.8, 45.2, 27.2, 23.5, 19.8, −1.9, −2.0 ppm; IR (thin film) ν: 3462, 3353, 3212, 2956, 2858, 1700, 1628, 1546, 1428, 1185, 1113 cm−1.

4.

To a solution of S3 (3.05 g, 3.78 mmol) in 38 mL of 1,2-dichloroethane at 50 °C was added Troc-benzimidazolium salt 1513 (2.13 g, 3.98 mmol, 1.05 equiv) in a single portion. The reaction mixture was stirred at this temperature for 2 h. Following this time, the reaction was cooled to room temperature and the mixture concentrated under reduced pressure to a brown oil. Purification of this material by chromatography on silica gel (gradient elution: 15:1 → 12:1 CH2Cl2/EtOAc) afforded 16 as a white foam (2.73 g, 74%). TLC Rf = 0.43 (2:1 hexanes/EtOAc); 1H NMR (500 MHz, CD3CN): δ 9.64 (d, 1H, J = 3.9 Hz), 7.58−7.52 (m, 6H), 7.45−7.32 (m, 10H), 6.41 (br s, 1H), 6.39 (dd, 1H, J = 1.6, 0.9 Hz), 6.18 (br s, 2H), 5.32 (br s, 1H), 4.87 (d, 1H, J = 11.9 Hz), 4.82 (d, 1H, J = 11.9 Hz), 4.60 (d, 1H, J = 11.2 Hz), 4.57 (d, 1H, J = 11.2 Hz), 4.03−3.98 (m, 1H), 3.62 (d, 2H, J = 5.7 Hz), 0.91 (s, 9H), 0.47 (s, 6H) ppm; 13C{1H} NMR (125 MHz, CD3CN): δ 163.0, 156.8, 154.7, 139.0, 136.24, 136.23, 134.7, 133.3, 133.2, 130.89, 130.88, 130.1, 128.79, 128.77, 128.76, 128.20, 125.5, 121.3, 117.3, 96.5, 95.1, 78.7, 75.7, 64.9, 57.2, 44.9, 26.9, 19.5, −2.04, −2.07 ppm; IR (thin film) ν: 3463, 3360, 3264, 2955, 2858, 1617, 1540, 1482, 1390, 1154, 1114 cm−1; HRMS (ES+): calcd for C38H45Cl6N6O6SSi2+, 979.0785 [M + H]+; found, 979.0783.

4.

A 25 mL oven-dried round-bottom flask was charged with Tces guanidine 16 (410 mg, 0.42 mmol) and Na2CO3 (221 mg, 2.09 mmol, 5 equiv). To this mixture was added 20 mL of CH2Cl2 followed by Dess–Martin periodinane (354 mg, 0.83 mmol, 2 equiv). The flask was placed in an oil bath heated to 40 °C, and the mixture was stirred at this temperature for 5 h. Following this time, the reaction mixture was cooled to room temperature and ~3 g of Celite and 10 mL of CH2Cl2 were added. The suspension was stirred for 10 min and then filtered through a pad of Celite. The flask and filter cake were rinsed with ~20 mL of CH2Cl2. The combined filtrates were concentrated under reduced pressure to a yellow foam. Purification of this material by chromatography on silica gel (gradient elution: 4:1 → 3:1 hexanes/EtOAc) afforded the desired tricycle 17 as a yellow solid (321 mg, 74%). TLC Rf = 0.26 (3:1 hexanes/EtOAc); 1H NMR (500 MHz, CD3CN): δ 9.25 (d, 1H, J = 2.9 Hz), 7.62−7.59 (m, 2H), 7.59−7.56 (m, 2H), 7.49−7.44 (m, 4H), 7.43−7.31 (m, 7H), 7.11 (br s, 1H), 7.08 (br s, 1H), 6.92 (s, 1H), 6.47 (s, 1H), 4.77 (d, 1H, J = 12.2 Hz), 4.71 (d, 1H, J = 12.2 Hz), 4.62 (s, 2H), 4.35−4.33 (m, 1H), 3.82−3.77 (m, 1H), 3.60 (dd, 1H, J = 10.3, 5.6 Hz), 3.42 (dd, 1H, J = 10.7, 8.6 Hz), 1.67 (s, 3H), 0.98 (s, 9H), 0.38 (s, 3H), 0.34 (s, 3H) ppm; 13C{1H} NMR (125 MHz, CD3CN): δ 170.3, 162.0, 159.3, 158.8, 143.6, 143.2, 136.23, 136.17, 134.9, 133.31, 133.30, 130.99, 130.5, 128.84, 128.82, 128.78, 96.7, 95.0, 88.2, 82.4, 78.7, 76.5, 64.2, 57.7, 56.5, 26.9, 21.1, 19.6, −3.1, −3.9 ppm; IR (thin film) ν: 3393, 2956, 2858, 1744, 1617, 1522, 1389 1268, 1114 cm−1; HRMS (ES+): calcd for C40H47Cl6N6O8SSi2+ 1037.0840 [M + H]+; found, 1037.0864.

4.

To a solution of N,O-acetal 17 (465 mg, 0.45 mmol) in 17 mL of CH2Cl2 was added thiophenol (230 μL, 2.25 mmol, 5.0 equiv) and BF3·OEt2 (170 μL, 1.35 mmol, 3.0 equiv). The mixture was stirred for 4 h, following which time the reaction was quenched by the addition of 20 mL of saturated aqueous NaHCO3. The biphasic mixture was stirred vigorously for 10 min and transferred to a separatory funnel containing 30 mL of EtOAc. The organic layer was collected, and the aqueous portion was extracted with 3 × 15 mL of EtOAc. The combined organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure to an oily residue. Purification of this material by chromatography on silica gel (gradient elution: 6:1 → 3:1 hexanes/EtOAc) afforded N,S-acetal S4 as a pale yellow foam (366 mg, 75%). TLC Rf = 0.23 (4:1 hexanes/EtOAc); 1H NMR (500 MHz, CD3CN): δ 9.34 (d, 1H, J = 1.9 Hz), 7.65−7.54 (m, 6H), 7.52−7.35 (m, 9H), 7.35−7.28 M, 5H), 7.08 (br s, 1H), 6.23 (d, 1H, J = 1.0 Hz), 6.02 (br s, 1H), 5.97 (d, 1H, J = 1.0 Hz), 4.63−4.60 (m, 3H), 4.42 (d, 1H, J = 12.9 Hz), 4.04 (d, 1H, J = 4.4 Hz), 3.74−3.67 (m, 2H), 3.42 (dd, 1H, J = 10.3, 8.5 Hz), 1.00 (s, 9H), 0.44 (s, 3H), 0.43 (s, 3H) ppm; 13C{1H} NMR (125 MHz, CD3CN): δ 162.1, 158.64, 158.61, 146.5, 139.2, 136.6, 136.29, 136.25, 135.4, 134.9, 133.34, 133.29, 133.2, 131.00, 130.98, 130.6, 130.0, 129.8, 128.89, 128.85, 128.8, 96.7, 95.0, 83.1, 78.7, 77.3, 76.0, 64.2, 56.3, 55.2, 27.0, 19.6, −2.0, −2.7 ppm; IR (thin film) ν: 3387, 3071, 2954, 2858, 1597, 1516, 1389, 1264, 1177, 1114 cm−1.

4.

To a solution of N,S-acetal S4 (366 mg, 0.34 mmol) in 13 mL of CH2Cl2 was added m-CPBA (58 mg, 0.34 mmol). The reaction mixture was stirred for 10 min and then quenched by the addition of 10 mL of saturated aqueous Na2S2O3. The biphasic mixture was stirred vigorously for 5 min and transferred to a separatory funnel containing 10 mL of EtOAc. The organic phase was collected and washed with 10 mL of 1 M NaOH. The organic phase was collected, and the aqueous layer was extracted with 3 × 10 mL of EtOAc. The combined organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure to a yellow solid. This material was purified by chromatography on silica gel (3:1 hexanes/EtOAc) to yield sulfoxide 20 as a pale yellow foam (349 mg, 94%). TLC Rf = 0.39 (3:1 hexanes/EtOAc); 1H NMR (500 MHz, CD3CN): δ 9.50 (br s, 1H), 8.18 (br s, 1H), 7.65−7.58 (m, 6H), 7.56−7.51 (m, 2H), 7.50−7.38 (m, 12H), 6.84 (br s, 1H), 6.60 (d, 1H, J = 1.0 Hz), 6.20 (d, 1H, J = 1.1 Hz), 4.66 (s, 2H), 4.46 (d, 1H, J = 12.4 Hz), 4.25 (d, 1H, J = 12.4 Hz), 3.86 (dd, 1H, J = 10.4, 3.8 Hz), 3.67 (d, 1H, J = 7.1 Hz), 3.62−3.57 (m, 1H), 3.54 (dd, 1H, J = 10.5, 8.4 Hz), 1.00 (s, 9H), 0.60 (s, 3H), 0.55 (s, 3H) ppm; 13C{1H} NMR (125 MHz, CD3CN): δ 161.7, 158.0, 157.6, 144.2, 141.4, 140.6, 136.3, 136.0, 135.0, 133.3, 132.6, 131.06, 131.03, 130.96, 130.0, 129.1, 128.86, 128.83, 126.0, 96.6, 95.1, 89.6, 85.2, 78.8, 75.8, 64.2, 53.6, 51.5, 27.0, 19.6, −2.7, −2.9 ppm; IR (thin film) ν: 3424, 3071, 2955, 2858, 1654, 1595, 1389, 1330, 1262, 1178, 1114 cm−1; HRMS (ES+): calcd for C44H49Cl6N6O7S2Si2+, 1103.0768 [M + H]+; found, 1103.0792.

To a solution of sulfoxide 20 (70 mg, 63 μmol) in 2.5 mL of 2,2,2-trichloroethanol was added sodium thiophenolate (9.5 mg, 72 μmol, 1.1 equiv). The mixture was stirred at 80 °C for 5 h and then concentrated under reduced pressure to an oily residue. Purification of this material by chromatography on silica gel (gradient elution: 5:1 → 3:1 hexanes/EtOAc) yielded allylic alcohol 21 as a white solid (56 mg, 88%). TLC Rf = 0.38 (2:1 hexanes/EtOAc); 1H NMR (500 MHz, CD3CN): δ 9.01 (d, 1H, J = 4.0 Hz), 7.61−7.56 (m, 4H), 7.55−7.51 (m, 2H), 7.47−7.42 (m, 2H), 7.41−7.33 (m, 7H), 7.18 (br s, 1H), 7.06 (br s, 1H), 6.65 (d, 1H, J = 2.3 Hz), 4.96−4.93 (m, 1H), 4.84 (d, 1H, J = 11.9 Hz), 4.63 (d, 1H, J = 11.9 Hz), 4.60 (d, 1H, J = 11.2 Hz), 4.57 (d, 1H, J = 11.2 Hz), 4.42−4.41 (m, 1H), 3.85 (d, 1H, J = 7.0 Hz), 3.81−3.76 (m, 1H), 3.64−3.57 (m, 2H), 0.95 (s, 9H), 0.41 (s, 3H), 0.39 (s, 3H) ppm; 13C{1H} NMR (125 MHz, CD3CN): δ 162.3, 159.5, 157.0, 138.0, 136.3, 135.5, 134.8, 133.2, 131.1, 130.2, 128.82, 128.80, 128.75, 120.5, 96.7, 94.9, 84.0, 82.6, 78.7, 75.5, 64.6, 59.7, 57.6, 26.9, 19.5, −2.62, −2.67 ppm; IR (thin film) ν: 3393, 2955, 2859, 1588, 1526, 1381, 1189, 1105 cm−1; HRMS (ES+): calcd for C38H45Cl6N6O7SSi2+, 995.0735 [M + H]+; found, 995.0745.

4.

4.

To a solution of 21 (50 mg, 50 μmol) in 2.5 mL of CH2Cl2 was added m-CPBA (11.8 mg, 68 μmol, 1.3 equiv). The solution was stirred for 3 h and then concentrated under reduced pressure. The off-white solids were dissolved in 2 mL of Et2O and transferred to a separatory funnel containing 2 mL of saturated aqueous Na2S2O3. The organic phase was collected, and the aqueous layer was extracted with 2 × 2 mL of Et2O. The combined organic extracts were washed with 3 × 3 mL of pH 7.5 phosphate buffer, dried over MgSO4, filtered, and concentrated under reduced pressure to a white solid. This material was unstable to purification by chromatography on silica gel and was used in the subsequent reaction without further purification. A sample of 26 suitable for analysis was obtained by purification on a short plug of Davisil (gradient elution: 3:1 → 1:1 hexanes/EtOAc). TLC Rf = 0.53 (3:2 hexanes/EtOAc); 1H NMR (600 MHz, CD3CN): δ 9.19−9.17 (m, 1H), 7.67−7.60 (m, 4H), 7.49−7.38 (m, 6H), 7.15 (br s, 1H), 7.10 (br s, 1H), 4.82 (d, 1H, J = 12.2 Hz), 4.70 (d, 1H, J = 12.2 Hz), 4.60 (d, 1H, J = 11.2 Hz), 4.57 (d, 1H, J = 11.2 Hz), 4.47 (br s, 1H), 4.31 (br s, 1H), 3.93 (d, 1H, J = 18.9 Hz), 3.87−3.74 (m, 4H), 1.02 (s, 9H) ppm; IR (thin film) ν: 3303, 2930, 2860, 1778, 1629, 1588, 1381, 1258, 1166, 1107 cm−1; HRMS (ES+): calcd for C30H35Cl6N6O8SSi+, 877.0132 [M + H]+; found, 877.0113.

4.

Alcohol S5 was prepared in an analogous manner to S1. Purification by chromatography on silica gel (3:2 hexanes/EtOAc) afforded S5 as a clear oil (3.5 g, 36% over 4 steps). TLC Rf = 0.3 (3:2 hexanes/EtOAc); 1H NMR (500 MHz, CDCl3): δ 7.29 (dd, 1H, J = 3.0, 2.1 Hz), 7.26−7.25 (m, 1H), 6.62 (d, 1H, J = 6.3 Hz), 6.31 (dd, 1H, J = 3.0, 1.5 Hz), 4.75−4.70 (m, 1H), 4.12−4.06 (m, 1H), 4.04−3.98 (m, 1H), 3.80 (s, 3H), 2.74 (t, 1H, J = 5.5 Hz), 0.88 (s, 9H), 0.17 (s, 6H) ppm; 13C{1H} NMR (125 MHz, CDCl3): δ 171.0, 150.9, 124.8, 120.0, 119.3, 117.7, 63.0, 55.7, 53.0, 26.4, 16.7, −5.5 ppm; IR (thin film) ν: 3362, 2954, 2855, 1741, 1701, 1543, 1479, 1380, 1250 cm−1.

4.

To a foil-wrapped flask containing alcohol S5 (14.7 g, 45 mmol) in 90 mL of THF, pyridine (18 mL, 223 mmol, 5.0 equiv) and AgNO3 (7.9 g, 46 mmol, 1.02 equiv) were added sequentially. The mixture was stirred for 10 min, following which time tBuPh2SiCl (11.5 mL, 45 mmol) was added dropwise over 5 min. The reaction mixture was stirred in the dark at room temperature for 13 h and then filtered through Celite. The flask and filter cake were rinsed with 50 mL of THF. The combined filtrates were transferred to a separatory funnel containing 300 mL of H2O. The organic phase was collected and washed sequentially with 250 mL of 1 M aqueous HCl and 250 mL of H2O. The organic layer was dried over MgSO4, filtered, and concentrated under reduced pressure to an oily residue. Purification of this material by chromatography on silica gel (gradient elution: 12:1 → 10:1 hexanes/EtOAc) afforded S6 as a clear oil (23.7 g, 93%). TLC Rf = 0.26 (9:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.60−7.56 (m, 4H), 7.46−7.30 (m, 6H), 7.22−7.21 (m, 1H), 7.20 (dd, 1H, J = 2.9, 1.9 Hz), 6.43 (d, 1H, J = 8.2 Hz), 6.34 (dd, 1H, J = 3.1, 1.7 Hz), 4.70 (dt, 1H, J = 8.2, 3.1 Hz), 4.20 (dd, 1H, J = 10.5, 2.9 Hz), 4.00 (dd, 1H, J = 10.2, 3.2 Hz), 3.80 (s, 3H), 1.05 (s, 9H), 0.91 (s, 9H), 0.19 (s, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3): δ 170.8, 150.2, 135.5, 135.4, 132.6, 132.5, 130.1, 128.0, 127.9, 124.7, 119.8, 119.2, 117.6, 64.3, 55.4, 52.8, 26.8, 26.5, 19.4, 16.8, −5.47, −5.49 ppm; IR (thin film) ν: 3439, 3361, 2950, 2930, 2857, 1750, 1713. 1506, 1475, 1250, 1113 cm−1.

4.

Amine S7 was prepared in an analogous manner to 12. Purification by chromatography on silica gel (gradient elution: 2:1 → 1:2 CH2Cl2/EtOAc) afforded S7 as a white foam (1.86 g, 53%). TLC Rf = 0.32 (3:2 CH2Cl2/EtOAc); 1H NMR (500 MHz, CDCl3): δ 7.62−7.56 (m, 4H), 7.44−7.31 (m, 7H), 6.13−6.11 (m, 1H), 5.89 (d, 1H, J = 3.0 Hz), 5.87−5.78 (m, 1H), 5.20−5.14 (m, 1H), 5.13−5.08 (m, 1H), 3.92 (d, 1H, J = 3.6 Hz), 3.73−3.68 (m, 1H), 3.62−3.53 (m, 2H), 3.30−3.24 (m, 1H), 3.23−3.16 (m, 1H), 1.02 (s, 9H), 0.89 (s, 9H), 0.18 (s, 6H) ppm; 13C{1H} NMR (125 MHz, CDCl3): δ 149.5, 136.4, 135.6, 132.76, 132.74, 130.0, 129.7, 127.9, 124.4, 118.2, 116.6, 115.5, 64.6, 58.6, 49.7, 49.5, 26.8, 26.5, 19.2, 16.8, −5.46, −5.54 ppm; IR (thin film) ν: 3242, 3122, 3073, 2953, 2930, 2856, 1717, 1471, 1428, 1249, 1176, 1113 cm−1.

4.

Isothiourea S8 was prepared in an analogous manner to S2. Purification by chromatography on silica gel (gradient elution: 4:1 → 2:1 hexanes/EtOAc) afforded S8 as a yellow foam (2.37 g, 89%). TLC Rf = 0.41 (2:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3): δ 8.14 (d, 1H, J = 8.7 Hz), 7.63−7.54 (m, 4H), 7.47−7.33 (m, 7H), 6.32 (dd, 1H, J = 1.6, 0.9 Hz), 6.05 (br s, 1H), 5.28−5.21 (m, 1H), 4.64 (s, 2H), 3.84−3.76 (m, 1H), 3.68 (dd, 1H, J = 10.5, 6.0 Hz), 3.54 (dd, 1H, J = 10.5, 6.5 Hz), 2.49 (s, 3H), 1.05 (s, 9H), 0.90 (s, 9H), 0.19 (d, 6H, J = 1.1 Hz) ppm; 13C{1H} NMR (100 MHz, CDCl3): δ 170.6, 149.0, 135.52, 135.51, 132.3, 132.1, 130.23, 130.21, 128.04, 128.02, 125.5, 125.4, 119.5, 117.3, 93.7, 78.6, 63.3, 57.9, 47.9, 26.8, 26.5, 19.2, 16.7, 14.7, −5.48, −5.51 ppm; IR (thin film) ν: 3283, 3134, 3073, 2953, 2930, 2857, 1717, 1572, 1428, 1352, 1166, 1113 cm−1.

4.

Isourea S9 was prepared in an analogous manner to 14. Purification by chromatography on silica gel (gradient elution: 1:0 → 4:1 hexanes/EtOAc) afforded S9 as a pale yellow foam (7.7 g, 79%). TLC Rf = 0.46 (4:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3): δ 8.06 (d, 1H, J = 8.9 Hz), 7.66−7.63 (m, 2H), 7.62−7.58 (m, 2H), 7.46−7.30 (m, 6H), 7.00 (d, 1H, J = 1.6 Hz), 6.36−6.34 (m, 1H), 5.39 (dd, 1H, J = 9.2, 4.2 Hz), 4.62 (s, 2H), 4.37−4.21 (m, 2H), 3.99 (quint, 1H, J = 8.0, 4.1 Hz), 3.73 (dd, 1H, J = 10.2, 4.1 Hz), 3.26 (dd, 1H, J = 10.2, 7.8 Hz), 2.50 (s, 3H), 1.37 (t, 3H, J = 6.5 Hz), 1.02 (s, 9H), 0.91 (s, 9H), 0.20 (s, 3H), 0.19 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3): δ 170.7, 146.9, 135.7, 135.6, 133.0, 132.9, 129.9, 129.8, 127.9, 127.8, 126.2, 123.0, 118.0, 116.2, 93.8, 78.6, 63.5, 63.1, 61.2, 48.2, 26.8, 26.6, 19.3, 16.8, 14.7, 14.2, −5.34, −5.38 ppm; IR (thin film) ν: 3288, 2390, 2954, 2885, 2857, 1668, 1573, 1477, 1427, 1335, 1163, 1113 cm−1.

4.

Bisguanidine S10 was prepared in an analogous manner to S3. Purification by chromatography on silica gel (1:1:0.01 hexanes/EtOAc/AcOH, then gradient elution: 14:1:0.01 → 9:1:0.01 CH2Cl2/MeOH/AcOH) afforded S10·HOAc as a white foam (1.15 g, 70%). TLC Rf = 0.4 (10:1:0.01 CH2Cl2/MeOH/AcOH); 1H NMR (400 MHz, CD3OD, S10·HOAc): δ 7.61−7.56 (m, 4H), 7.51 (d, 1H, J = 1.4 Hz), 7.46−7.37 (m, 6H), 6.52−6.51 (m, 1H), 5.47 (br s, 1H), 4.64 (s, 2H), 3.95−3.92 (m, 1H), 3.71 (dd, 1H, J = 11.5, 4.7 Hz), 3.64 (dd, 1H, J = 10.6, 5.3 Hz), 1.93 (s, 3H), 0.92 (s, 9H), 0.91 (s, 9H), 0.21 (s, 3H), 0.20 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CD3OD, S10·HOAc): δ 179.7, 157.5, 151.8, 136.66, 136.65, 133.5, 133.3, 131.14, 131.11, 129.2, 129.0, 125.1, 124.0, 118.9, 95.6, 79.3, 65.6, 57.8, 45.1, 27.3, 26.9, 23.4, 19.9, 17.5, −5.36, −5.39 ppm; IR (thin film) ν: 3463, 3359, 3231, 2930, 2858, 1697, 1628, 1546, 1413, 1331, 1185, 1114 cm−1.

4.

Bisguanidine S11 was prepared in an analogous manner to 16. Purification by chromatography on silica gel (gradient elution: 4:1 → 2:1 hexanes/EtOAc) afforded S11 as a white foam (1.23 g, 88%). TLC Rf = 0.31 (3:1 hexanes/EtOAc); 1H NMR (500 MHz, CD3CN): δ 9.65 (d, 1H, J = 3.3 Hz), 7.59−7.53 (m, 4H), 7.47−7.35 (m, 7H), 6.41−6.35 (m, 2H), 6.19 (br s, 2H), 5.32 (br s, 1H), 4.88 (d, 1H, J = 12.4 Hz), 4.84 (d, 1H, J = 12.4 Hz), 4.61 (d, 1H, J = 11.3 Hz), 4.59 (d, 1H, J = 11.3 Hz), 4.04−3.99 (m, 1H), 3.65−3.59 (m, 2H), 0.93 (s, 9H), 0.88 (s, 9H), 0.19 (s, 3H), 0.18 (s, 3H) ppm; 13C{H} NMR (125 MHz, CD3CN): δ 163.0, 153.9, 154.7, 136.24, 136.21, 133.32, 133.27, 130.90, 128.8, 127.7, 125.5, 125.3, 120.5, 118.0, 96.5, 95.1, 78.7, 75.7, 64.9, 57.2, 44.9, 27.0, 26.7, 19.5, 17.1, −5.43, −5.47 ppm; IR (thin film) ν: 3462, 3358, 2954, 2857, 1617, 1540, 1482, 1389, 1154, 1114 cm−1.

N,O-Acetal S12 was prepared in an analogous manner to 17. Purification by chromatography on silica gel (gradient elution: 4:1 → 3:1 hexanes/EtOAc) afforded S12 as a yellow foam (516 mg, 54%). TLC Rf = 0.30 (3:1 hexanes/EtOAc); 1H NMR (500 MHz, CD3CN): δ 9.26 (d, 1H, J = 3.1 Hz), 7.63−7.59 (m, 2H), 7.57−7.53 (m, 2H), 7.49−7.37 (m, 6H), 7.09 (br s, 1H), 7.04 (br s, 1H), 6.98 (s, 1H), 6.47 (s, 1H), 4.84 (d, 1H, J = 12.5 Hz), 4.74 (d, 1H, J = 12.5 Hz), 4.63 (d, 1H, J = 11.1 Hz), 4.60 (d, 1H, J = 11.1 Hz), 4.36 (br s, 1H), 3.84−3.79 (m, 1H), 3.57 (dd, 1H, J = 10.8, 5.4 Hz), 3.38 (dd, 1H, J = 10.6, 9.0 Hz), 2.04 (s, 3H), 0.98 (s, 9H), 0.78 (s, 9H), 0.10 (s, 3H), 0.02 (s, 3H) ppm; 13C{1H} NMR (125 MHz, CD3CN): δ 170.3, 162.0, 159.5, 158.8, 144.2, 142.8, 136.3, 136.1, 133.3, 131.01, 130.99, 128.86, 128.85, 96.8, 95.0, 88.1, 82.1, 78.7, 76.6, 63.9, 58.3, 56.7, 26.9, 26.7, 21.7, 19.5, 17.2, −5.8, −6.0 ppm; IR (thin film) ν: 3403, 2931, 2858, 1749, 1617, 1522, 1389, 1178, 1114 cm−1.

4.

4.

N,S-Acetal S13 was prepared in an analogous manner to S4. Purification by chromatography on silica gel (gradient elution: 6:1 → 4:1 hexanes/EtOAc) afforded S13 as a pale yellow foam (193 mg, 74%). TLC Rf = 0.53 (3:1 hexanes/EtOAc); 1H NMR (500 MHz, CD3CN): δ 9.33 (d, 1H, J = 2.3 Hz), 7.82−7.78 (m, 2H), 7.64−7.60 (m, 2H), 7.59−7.55 (m, 2H), 7.48−7.34 (m, 9H), 7.06 (br s, 1H), 6.32 (br s, 1H), 6.26 (d, 1H, J = 1.0 Hz), 6.16 (d, 1H, J = 0.8 Hz), 4.68 (d, 1H, J = 12.3 Hz), 4.63 (s, 2H), 4.43 (d, 1H, J = 12.3 Hz), 4.09 (d, 1H, J = 4.1 Hz), 3.77−3.72 (m, 1H), 3.67 (dd, 1H, J = 10.3, 4.7 Hz), 3.41 (dd, 1H, J = 10.3, 8.9 Hz), 0.99 (s, 9H), 0.78 (s, 9H), 0.17 (s, 3H), 0.15 (s, 3H) ppm; 13C{1H} NMR (125 MHz, CD3CN): δ 161.5, 158.1, 158.0, 145.2, 139.3, 135.8, 135.7, 134.5, 133.0, 132.8, 132.7, 130.43, 130.40, 129.5, 129.1, 128.27, 128.25, 96.2, 94.4, 82.2, 78.1, 76.8, 75.5, 63.3, 56.1, 54.6, 26.4, 26.3, 19.0, 16.8, −5.3, −5.8 ppm; IR (thin film) ν: 3385, 2930, 2858, 1596, 1517, 1390, 1252, 1177, 1114 cm−1.

4.

Sulfoxide S14 was prepared in an analogous manner to 20. Purification by chromatography on silica gel (gradient elution: 4:1 → 7:2 hexanes/EtOAc) afforded S14 as a yellow foam (187 mg, 96%). TLC Rf = 0.34 (3:1 hexanes/EtOAc); 1H NMR (400 MHz, CD3CN): δ 9.48 (br s, 1H), 8.24 (br s, 1H), 7.67−7.57 (m, 6H), 7.54−7.36 (m, 9H), 6.86 (br s, 1H), 6.62 (d, 1H, J = 1.1 Hz), 6.36 (d, 1H, J = 0.9 Hz), 4.66 (s, 2H), 4.60 (d, 1H, J = 12.1 Hz), 4.31 (d, 1H, J = 12.1 Hz), 3.85 (dd, 1H, J = 10.2, 3.6 Hz), 3.71 (d, 1H, J = 7.0 Hz), 3.63−3.57 (m, 1H), 3.54 (dd, 1H, J = 10.2, 8.4 Hz), 0.99 (s, 9H), 0.92 (s, 9H), 0.32 (s, 3H), 0.26 (s, 3H) ppm; IR (thin film) ν: 3245, 2956, 2931, 2858, 1653, 1595, 1390, 1263, 1178, 1114 cm−1.

4.

Allylic alcohol S15 was prepared in an analogous manner to 21. Purification by chromatography on silica gel (gradient elution: 5:1 → 3:1 hexanes/EtOAc) afforded S15 as a yellow foam (142 mg, 84%). TLC Rf = 0.45 (2:1 hexanes/EtOAc); 1H NMR (500 MHz, CD3CN): δ 9.03 (d, 1H, J = 4.4 Hz), 7.63−7.57 (m, 4H), 7.49−7.37 (m, 6H), 7.17 (br s, 1H), 7.06 (br s, 1H), 6.79, (d, 1H, J = 2.2 Hz), 4.97 (dd, 1H, J = 7.3, 2.4 Hz), 4.86 (d, 1H, J = 12.5 Hz), 4.65 (d, 1H, J = 12.5 Hz), 4.60 (d, 1H, J = 11.3 Hz), 4.58 (d, 1H, J = 11.3 Hz), 4.42 (br s, 1H), 3.85 (d, 1H, J = 7.3 Hz), 3.84−3.80 (m, 1H), 3.64 (dd, 1H, J = 10.4, 5.4 Hz), 3.59 (dd, 1H, J = 10.5, 7.8 Hz), 0.98 (s, 9H), 0.87 (s, 9H), 0.11 (s, 3H), 0.10 (s, 3H) ppm; 13C{1H} NMR (125 MHz, CD3CN): δ 162.4, 159.6, 157.0, 136.23, 136.21, 135.3, 133.3, 133.2, 130.96, 130.95, 128.83, 128.82, 119.9, 96.7, 94.9, 84.6, 82.5, 78.7, 75.5, 64.2, 59.5, 57.5, 27.1, 27.0, 19.5, 17.3, −5.0, −5.9 ppm; IR (thin film) ν: 3290, 2953, 2858, 1594, 1524, 1381, 1188, 1105 cm−1.

4.

To a solution of S15 (61 mg, 62 μmol) in 2.5 mL of CH2Cl2 was added m-CPBA (10.7 mg, 62 μmol). The solution was stirred for 2.5 h and then quenched by the addition of 3 mL of saturated aqueous Na2S2O3. The biphasic mixture was transferred to a separatory funnel containing 3 mL of EtOAc. The organic phase was collected, and the aqueous layer was extracted with 2 × 3 of mL EtOAc. The combined organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure. Purification of this material by chromatography on silica gel (gradient elution: 7:2 → 3:1 hexanes/EtOAc) afforded 24 as a white solid (47 mg, 76%). Note: if m-CPBA remains following workup and chromatographic purification, 24 can be dissolved in Et2O and washed with pH 7.5 phosphate buffer. The use of 1 M aqueous NaOH should be avoided, as basic solutions will decompose 24. TLC Rf = 0.38 (2:1 hexanes/EtOAc); 1H NMR (500 MHz, CD3CN): δ 8.97 (d, 1H, J = 4.1 Hz), 7.68−7.63 (m, 4H), 7.50−7.38 (m, 6H), 7.16 (br s, 1H), 6.86 (br s, 1H), 4.88 (d, 1H, J = 12.2 Hz), 4.61−4.55 (m, 3H), 4.52 (br s, 1H), 4.26 (br s, 1H), 4.24 (s, 1H), 3.90−3.85 (m, 1H), 3.83−3.79 (m, 1H), 3.74 (dd, 1H, J = 10.0, 6.9 Hz), 1.02 (s, 9H), 1.00 (s, 9H), −0.12 (s, 3H), −0.23 (s, 3H) ppm; 13C{1H} NMR (150 MHz, CD3CN, determined by HSQC and HMBC): δ 206.8, 161.5, 160.3, 159.2, 136(2), 133.1(2), 130.4(2), 128.3(2), 96.4, 94.1, 80.1, 79.7, 78.0, 74.8, 62.4, 59.3, 56.7, 55.2, 26.6, 26.3, 19.4, 17.6, −6.7(2) ppm; IR (thin film) ν: 3403, 2931, 2859, 1751, 1627, 1521, 1387, 1238, 1178, 1112 cm−1; HRMS (ES+): calcd for C36H49Cl6N6O8SSi2+, 991.0997 [M + H]+; found, 991.1020.

4.

A flask containing anhydrous CeCl3 (45 mg, 0.18 mmol, 6.7 equiv) was heated under vacuum to 160 °C for 2 h. The flask was then cooled to 0 °C, and 0.5 mL of THF was added. The white suspension was stirred at 0 °C for 30 min, and a 2.4 M ethereal solution of MeMgBr (80 μL, 0.19 mmol, 7.1 equiv) was added. The mixture was stirred at 0 °C for 45 min. Following this time, an ice-cold solution of 26 (24 mg, 27 μmol) in 0.3 mL of THF was added dropwise via a cannula. Transfer of 26 was made quantitative with an additional 0.2 mL of THF. The mixture was stirred at 0 °C for 5 min and then quenched by the addition of 3 mL of saturated aqueous NH4Cl. The contents were stirred vigorously for 10 min while the biphasic mixture warmed to room temperature. The mixture was transferred to a separatory funnel containing 2 mL of EtOAc. The organic phase was collected, and the aqueous portion was extracted with 3 × 2 mL of EtOAc. The combined organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure. Purification of this material by chromatography on silica gel (gradient elution: 2:1 → 1:1 hexanes/EtOAc) afforded S16 as a colorless film (4.3 mg, 20%, >20:1 dr). TLC Rf = 0.21 (1:1 hexanes/EtOAc); 1H NMR (600 MHz, CD3CN): δ 9.10−9.08 (m, 1H), 7.68−7.60 (m, 4H), 7.51−7.38 (m, 6H), 6.74 (br s, 1H), 4.79 (d, 1H, J = 12.6 Hz), 4.67 (d, 1H, J = 12.6 Hz), 4.60 (d, 1H, J = 11.2 Hz), 4.57 (d, 1H, J = 11.2 Hz), 4.12 (d, 1H, J = 2.8 Hz), 3.73−3.54 (m, 6H), 3.28 (d, 1H, J = 12.4 Hz), 1.24 (s, 3H), 1.02 (s, 9H) ppm; 13C{1H} NMR (150 MHz, CD3CN, determined by HSQC and HMBC): δ 162.0, 159.6, 135.8(2), 132.9(2), 130.4(2), 128.3(2), 96.6, 94.7, 80.2, 78.2, 77.1, 74.2, 74.0, 62.7, 55.9, 55.5, 54.9, 27.0, 21.8, 19.2 ppm; IR (thin film) ν: 3300, 2931, 2862, 1617, 1584, 1383, 1174, 1113 cm−1; HRMS (ES+): calcd for C31H39Cl6N6O8SSi+, 893.0445 [M + H]+; found, 893.0452.

4.

To a flame-dried 5 mL Schlenk flask was added 103 mg of indium powder under a positive pressure of argon. The flask was placed under an argon atmosphere, and 2.0 mL of THF was added, followed by 4 μL of 1,2-dibromoethane. To this suspension was added 77 μL of allylbromide. The mixture was stirred at 50 °C for 15 min and then cooled to room temperature. The freshly prepared allylindium solution (140 μL, 60 μmol, 6.0 equiv) was added dropwise via syringe to a −78 °C solution of α-hydroxyketone 26 (8.8 mg, 10 μmol) in 1.0 mL of THF. The reaction mixture was warmed to 15 °C over 4 h and quenched at this temperature by the addition of 1 mL of saturated aqueous NH4Cl. The mixture was transferred to a separatory funnel containing 1 mL of EtOAc, the organic layer was collected, and the aqueous phase was extracted with 3 × 1 mL of EtOAc. The combined organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure to a clear film. Purification of this material by chromatography on silica gel (3:2 hexanes/EtOAc) afforded diol S17 as a clear film (4.4 mg, 47%). TLC Rf = 0.43 (1:1 hexanes/EtOAc); 1H NMR (600 MHz, CD3CN): δ 9.09 (d, J = 2.6 Hz, 1H), 7.68−7.64 (m, 2H), 7.64−7.60 (m, 2H), 7.52−7.40 (m, 7H), 7.37 (s, 1H), 6.78 (s, 1H), 5.78 (dddd, J = 16.9, 10.2, 8.0, 6.6 Hz, 1H), 5.18−5.08 (m, 2H), 4.80 (d, J = 12.2 Hz, 1H), 4.67 (d, J = 12.3 Hz, 1H), 4.63−4.56 (m, 2H), 4.19−4.13 (m, 1H), 3.99 (s, 1H), 3.74−3.68 (m, 2H), 3.68−3.63 (m, 1H), 3.59−3.56 (m, 1H), 3.55−3.53 (m, 1H), 3.52 (d, J = 12.5 Hz, 1H), 3.36 (d, J = 12.4 Hz, 1H), 2.40 (ddt, J = 14.0, 6.6, 1.3 Hz, 1H), 2.20−2.16 (m, 1H), 1.03 (s, 9H) ppm; 13C{1H} NMR (150 MHz, CD3CN, determined by HMBC/HSQC): δ 19.7, 27.1, 41.2, 54.8, 55.6, 56.4, 63.4, 75.0, 76.5, 77.8, 77.9, 78.3, 95.0, 96.9, 119.2, 128.9, 131.3, 133.5, 133.5, 136.4, 159.9, 160.5, 162.4 ppm; IR (thin film) ν: 3305, 3073, 2931, 1732, 1614, 1538, 1471, 1428, 1386, 1270, 1170 cm−1; LCMS (ES+): calcd for C33H41Cl6N6O8SSi+, 919.1 [M + H]+; found, 919.0.

4.

To an ice-cold suspension of sodium hydride (12 mg, 0.50 mmol) in 3.0 mL of THF was added triethyl phosphonoacetate (112 μL, 0.55 mmol) dropwise via syringe. Gas evolution was immediately observed and the gray suspension turned into a clear solution. The mixture was warmed to room temperature and stirred for 15 min. To a solution of hydroxyketone 26 (88 mg, 0.1 mmol) in 5 mL of THF at −40 °C was added the triethyl phosphonoacetate solution (790 μL, 0.12 mmol, 1.2 equiv) dropwise via syringe. The reaction mixture was stirred at this temperature for 1 h and then slowly warmed to 0 °C over a 3 h period. Following this time, the reaction mixture was quenched at 0 °C by the addition of 5 mL of saturated aqueous NH4Cl and then transferred to a separatory funnel containing 5 mL of EtOAc. The organic layer was collected, and the aqueous phase was extracted with 3 × 5 mL of EtOAc. The combined organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure to a yellow oil. Purification of this material by chromatography on silica gel (3:1 hexanes/EtOAc) afforded a mixture of α,β-unsaturated esters 30 and 31 as white foams (36 mg, 37%, Z/E ratio = 3:2). Spectral data for 30: TLC Rf = 0.50 (3:2 hexanes/EtOAc); 1H NMR (600 MHz, CD3CN) : δ 9.03 (d, J = 3.8 Hz, 1H), 7.64−7.62 (m, 2H), 7.61−7.58 (m, 2H), 7.48−7.44 (m, 2H), 7.41 (tdd, J = 8.1, 5.1, 1.0 Hz, 5H), 7.08 (s, 1H), 7.00 (s, 1H), 6.07 (dd, J = 3.5, 2.2 Hz, 2H), 4.81 (d, J = 12.2 Hz, 1H), 4.78 (d, J = 2.5 Hz, 1H), 4.69 (d, J = 12.2 Hz, 1H), 4.58 (d, J = 1.5 Hz, 2H), 4.46 (q, J = 1.3 Hz, 1H), 4.26−4.20 (m, 4H), 3.82 (ddq, J = 7.4, 3.8, 1.9 Hz, 1H), 3.74 (dd, J = 10.5, 5.4 Hz, 1H), 3.70 (dd, J = 10.5, 7.7 Hz, 1H), 1.28 (t, J = 7.1 Hz, 3H), 1.02 (s, 9H) ppm; 13C{1H} NMR (125 MHz, CD3CN): δ 168.6, 162.3, 159.8, 156.8, 136.4, 136.3, 133.4, 131.0, 131.0, 128.9, 128.8, 117.8, 96.8, 95.0, 80.6, 78.7, 77.6, 75.6, 64.1, 62.6, 59.0, 56.2, 50.4, 27.0, 19.6, 14.2 ppm; IR (thin film) ν: 3313, 2932, 1623, 1586, 1535, 1472, 1428, 1377, 1313, 1233, 1170, 1113 cm−1; HRMS (ES+): calcd for C34H41Cl6N6O9SSi+, 947.0551 [M + H]+; found, 947.0538.

Spectral data for 31: TLC Rf = 0.36 (3:2 hexanes/EtOAc); 1H NMR (600 MHz, CD3CN): δ 9.03 (d, J = 3.6 Hz, 1H), 7.65−7.62 (m, 2H), 7.62−7.60 (m, 2H), 7.49−7.44 (m, 2H), 7.44−7.39 (m, 4H), 7.11 (s, 1H), 6.82 (s, 1H), 5.96 (q, J = 2.6 Hz, 1H), 4.83 (d, J = 12.2 Hz, 1H), 4.71 (d, J = 12.2 Hz, 1H), 4.58 (d, J = 1.0 Hz, 2H), 4.51 (d, J = 2.6 Hz, 2H), 4.48 (t, J = 2.5 Hz, 1H), 4.43 (d, J = 1.9 Hz, 1H), 4.33−4.27 (m, 2H), 4.20 (qd, J = 7.1, 5.3 Hz, 2H), 3.84−3.78 (m, 1H), 3.76 (dd, J = 10.5, 5.2 Hz, 1H), 3.71 (dd, J = 10.5, 7.7 Hz, 1H), 1.28 (t, J = 7.1 Hz, 3H), 1.03 (s, H) ppm; 13C NMR (125 MHz, CD3CN): δ 166.2, 162.3, 160.0, 159.6, 154.6, 136.4, 136.3, 133.8, 133.5, 133.4, 131.0, 131.0, 128.9, 128.8, 116.0, 96.8, 95.0, 78.8, 78.7, 77.6, 75.6, 64.2, 61.3, 58.1, 56.2, 48.9, 27.1, 19.6, 14.5 ppm; IR (thin film) ν: 3297, 3073, 2932, 2859, 1708, 1583, 1472, 1428, 1382, 1350, 1266, 1163 cm−1; HRMS (ES+): calcd for C34H41Cl6N6O9SSi+, 947.0551 [M + H]+; found, 947.0558.

4.

To a solution of α,β-unsaturated esters 30 and 31 (7 mg, 7.3 μmol) in 0.7 mL of CH2Cl2 was added Dess–Martin periodinane (4 mg, 8.7 μmol, 1.2 equiv). The suspension was stirred for 3 h, following which time the reaction was quenched by the addition of 1 mL of saturated aqueous NH4Cl. The mixture was transferred to a separatory funnel containing 2 mL of EtOAc, the organic layer collected, and the aqueous phase extracted with 3 × 2 mL of EtOAc. The combined organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure to a yellow oil. Purification of this material by chromatography on silica gel (3:1 hexanes/EtOAc) afforded ketoester 32 as a white foam (5 mg, 76%, exclusively E-isomer). TLC Rf = 0.43 (3:2 hexanes/EtOAc); 1H NMR (600 MHz, CD3CN): δ 8.99 (d, J = 3.9 Hz, 1H), 7.53 (dq, J = 6.7, 1.5 Hz, 4H), 7.47−7.41 (m, 2H), 7.38 (tdd, J = 8.1, 2.9, 1.0 Hz, 4H), 7.14 (s, 1H), 6.62 (t, J = 2.8 Hz, 1H), 4.87 (d, J = 12.2 Hz, 1H), 4.71 (d, J = 12.2 Hz, 1H), 4.71−4.66 (m, 1H), 4.62−4.59 (m, 3H), 4.49 (dd, J = 18.5, 3.0 Hz, 1H), 4.32−4.24 (m, 2H), 3.88−3.84 (m, 1H), 3.62 (dd, J = 10.7, 5.4 Hz, 1H), 3.59 (dd, J = 10.7, 6.8 Hz, 1H), 1.32 (t, J = 7.1 Hz, 3H), 0.97 (s, 9H) ppm; 13C{1H} NMR (150 MHz, CD3CN, determined by HMBC and HSQC): δ 194.5, 165.4, 162.3, 160.7, 158.8, 141.6, 136.3, 133.3, 131.0, 128.8, 125.5, 96.6, 95.0, 78.7, 75.6, 75.5, 64.7, 62.6, 58.7, 56.2, 47.7, 27.0, 19.6, 14.5 ppm; IR (thin film) ν: 3302, 3072, 2930, 2858, 1754, 1718, 1587, 1529, 1472, 1428, 1385, 1313, 1113 cm−1; HRMS (ES+): calcd for C34H39Cl6N6O9SSi, 945.0394 [M + H]+; found, 945.0393.

4.

A flame-dried 5 mL round-bottom flask containing 32 (31 mg, 33 μmol) and [Ir(cod)(PCy3)(py)]PF6 (8.0 mg, 10 μmol, 0.3 equiv) was capped with a rubber septum and flushed with N2. The solids were dissolved in 300 μL of CH2Cl2, and neat B(OiPr)3 (6.2 μL, 33 μmol, 1.0 equiv) was added via syringe. The line feeding N2 was removed, a 21-gauge disposable needle was inserted into the rubber septum, and the reaction vessel was placed in a high pressure Parr bomb. The bomb was sealed and flushed twice with H2 gas (500 psi) and then pressurized to 500 psi of H2. The contents were stirred under this pressure of H2 for 16 h. Following this time, the Parr bomb was vented, the flask unsealed, and 1 mL of saturated aqueous NH4Cl was added to the reaction mixture. The reaction mixture was stirred vigorously for 2 min and then transferred to a separatory funnel containing 3 mL of EtOAc. The organic layer was collected, and the aqueous fraction was extracted with 2 × 5 mL of EtOAc. The combined organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure to an orange film. Purification of this material by preparative TLC on silica gel (1:1 hexanes/EtOAc) afforded ketone 33 as a white solid (11 mg, 35%, 2.5:1 mixture of diastereomers). TLC Rf = 0.4 (3:2 hexanes/EtOAc); 1H NMR (600 MHz, CD3CN, major diastereomer): δ 9.00 (d, J = 4.1 Hz, 1H), 7.62−7.55 (m, 4H), 7.51−7.45 (m, 2H), 7.45−7.39 (m, 4H), 4.84 (d, J = 12.2 Hz, 1H), 4.65 (d, J = 12.2 Hz, 1H), 4.62 (d, J = 11.0 Hz, 1H), 4.59 (d, J = 11.2 Hz, 1H), 4.44 (s, 1H), 4.13 (qd, J = 7.2, 1.2 Hz, 2H), 4.04−4.00 (m, 1H), 3.86−3.82 (m, 1H), 3.65−3.56 (m, 2H), 3.33 (dd, J = 11.3, 9.1 Hz, 1H), 2.89 (dd, J = 18.4, 5.1 Hz, 1H), 2.69 (dd, J = 14.6, 4.0 Hz, 1H), 2.46 (tdd, J = 9.2, 5.0, 3.8 Hz, 1H), 1.22 (t, J = 7.1 Hz, 3H), 1.01 (s, 9H) ppm; 13C{1H} NMR (150 MHz, determined by HSQC/HMBC, CD3CN, major diastereomer): δ 208.9, 173.1, 162.5, 161.1, 159.8, 136.3, 133.6, 131.2, 128.8, 97.1, 95.1, 79.0, 76.3, 75.8, 63.6, 63.1, 59.8, 59.4, 46.1, 41.7, 32.6, 27.3, 20.2, 14.5 ppm; IR (thin film) ν: 3311, 2930, 1721, 1658, 1639, 1586 cm−1; HRMS (ES+): calcd for C34H41Cl6N6O9SSi, 947.0551 [M + H]+; found, 947.0556.

4.

To 9.0 mL of THF was added 70 μL of AcOH and 1.0 mL of a 1.0 M solution of n-Bu4NF in THF. The freshly prepared mixture was cooled to −78 °C, and 400 μL (40 μmol, 1.2 equiv) was added dropwise to a −78 °C solution of α,β-unsaturated ester 30 (31 mg, 33 μmol) in 3.0 mL of THF. The reaction mixture was stirred for 1 h at −78 °C and then warmed to 0 °C over a 2 h period. Following this time, the reaction was quenched by the addition of 1 mL of saturated aqueous NH4Cl. The mixture was stirred vigorously for 5 min and transferred to a separatory funnel containing 2 mL of EtOAc. The organic layer was separated and the aqueous layer was extracted with 3 × 2 mL of EtOAc. The combined organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure to a white film. Purification of this material by chromatography on silica gel (gradient elution: 1:1 → 0:1 hexanes/EtOAc) afforded alcohol 34 as a white foam (17 mg, 76%). TLC Rf = 0.25 (1:2 hexanes/EtOAc); 1H NMR (600 MHz, CD3CN): δ 8.88 (s, 1H), 4.89 (d, J = 12.2 Hz, 1H), 4.69 (d, J = 12.3 Hz, 1H), 4.64−4.58 (m, 2H), 4.50 (d, J = 1.6 Hz, 1H), 4.34 (dd, J = 11.5, 9.6 Hz, 1H), 4.15 (q, J = 7.1 Hz, 2H), 3.69 (d, J = 4.3Hz, 1H), 3.62−3.52 (m, 2H), 3.41 (dd, J = 11.5, 9.2 Hz, 1H), 3.30 (s, 1H), 2.98 (dd, J = 18.3, 4.9 Hz, 1H), 2.86 (tt, J = 9.2, 4.4 Hz, 1H), 2.77 (dd, J = 18.3, 3.9 Hz, 1H), 1.25−1.20 (m, 3H) ppm; 13C{1H} NMR (125 MHz, CD3CN): δ 209.2, 173.1, 162.5, 161.4, 159.0, 96.9, 95.0, 78.8, 76.3, 75.6, 64.5, 62.5, 60.0, 55.0, 46.6, 41.6, 33.0, 14.3 ppm; IR (thin film) ν: 3312, 2925, 1772, 1716, 1585, 1380, 1203 cm−1; HRMS (ES+): calcd for C18H23Cl6N6O9S+, 708.9373 [M + H]+; found, 708.9379.

4.

To an ice-cold solution of alcohol 34 (6.5 mg, 9.1 μmol) in 900 μL of THF was added 1,1′-carbonyldiimidazole (7.4 mg, 46 μmol, 5.0 equiv). The reaction mixture was stirred at 0 °C for 3 h, following which time a second portion of carbonyldiimidazole (7.4 mg, 46 μmol, 5.0 equiv) was added. After stirring for an additional 2 h, the reaction was quenched by the addition of 1 mL of saturated aqueous NH4Cl. The solution was transferred to a separatory funnel containing 2 mL of THF, the aqueous layer was collected, and the organic phase was washed with 1 × 5 mL of saturated aqueous NaCl. The combined organic extracts were dried over MgSO4, filtered, and concentrated under reduced pressure to a colorless film. This material was dissolved in 1.0 mL of a saturated solution of NH3 in THF (generated by bubbling ammonia gas through a solution of THF for 5 min) and the flask sealed with a yellow polyethylene cap and the stopper wrapped in Parafilm. After stirring for 24 h, the flask was unsealed and an additional 1.0 mL of the saturated NH3 in THF solution was added. The flask was restoppered and stirring continued for an additional 12 h. Following this time, the reaction mixture was concentrated under reduced pressure to a colorless film. Purification of this material by preparative TLC on silica gel (EtOAc) gave carbamate S18 as a colorless film (3.7 mg, 54%). 1H NMR (600 MHz, CD3CN): δ 8.86 (d, J = 4.2 Hz, 1H), 4.89 (d, J = 12.2 Hz, 1H), 4.70 (d, J = 12.2 Hz, 1H), 4.60 (d, J = 6.4 Hz, 2H), 4.50 (s, 1H), 4.23 (dd, J = 11.3, 9.0 Hz, 1H), 4.15 (tdd, J = 7.1, 6.4, 1.1 Hz, 2H), 4.06 (d, J = 6.2 Hz, 2H), 3.81 (tdd, J = 7.0, 4.8, 1.6 Hz, 1H), 3.62−3.53 (m, 1H), 3.44−3.38 (m, 1H), 3.05−2.96 (m, 2H), 2.85−2.77 (m, 1H), 1.23 (t, J = 7.2 Hz, 3H) ppm; 13C{1H} NMR (150 MHz, determined by HMBC/HSQC, CD3CN): δ 209.0, 173.1, 162.5, 161.6, 157.0, 96.9, 94.9, 76.4, 78.5, 75.4, 63.6, 62.3, 58.7, 54.2, 45.9, 41.0, 32.6, 14.2 ppm; IR (thin film) ν: 3310, 1771, 1720, 1587, 1529, 1381, 1331, 1259, 1235, 1206, 1177, 1151, 1109, 1020 cm−1; HRMS (ES+): calcd for C19H24Cl6N7O10S+, 751.9431 [M + H]+; found, 751.9441.

4.

To a solution of carbamate S18 (4.8 mg, 6.4 μmol) in 1.9 mL of MeOH was added 640 μL of H2O and 74 μL of CF3CO2H. The mixture was stirred for 1 h, after which time PdCl2 (0.6 mg, 3.2 μmol, 0.5 equiv) was added. The reaction was sparged with N2 and then H2 for 5 min until the solution turned black. A balloon of H2 was attached to the reaction flask and the mixture was stirred for 3 h. Following this time, the reaction was filtered through a 0.45 μm PTFE filter. The reaction flask and filter were rinsed with 3 × 3 mL of H2O. The combined filtrates were concentrated under reduced pressure to a white film, which was redissolved in 3.0 mL of 1.0 M aqueous HCl. The solution was stirred for 40 h. The aqueous solution was then lyophilized to remove all volatiles. The isolated material was purified by reverse-phase HPLC (SiliCycle C18, 5 μM, 10 × 250 mm column, eluting with gradient flow over 30 min of 5:95 → 25:75 MeCN/10 mM aqueous C3F7CO2H, 214 nm UV detection). At a flow rate of 4 mL/min, 11-SEA7 had a retention time of 10–11 min and was isolated as a white hygroscopic solid following lyophilization (285 μg, 12.4%). 1H NMR (600 MHz, D2O, spectrum recorded immediately after dissolving the sample in D2O): δ 4.80 (s, 1H, by HSQC), 4.28 (dd, J = 11.7, 9.1 Hz, 1H), 4.06 (dd, J = 11.7, 5.3 Hz, 1H), 3.95 (t, J = 9.4 Hz, 1H), 3.83 (ddd, J = 9.1, 5.3, 1.4 Hz, 1H), 3.26−3.19 (m, 1H), 2.80 (ddd, J = 16.6, 9.8, 6.8 Hz, 1H), 2.75−2.66 (m, 1H), 2.54 (dd, J = 16.3, 6.3 Hz, 1H) ppm; 1H NMR (600 MHz, D2O, after 15 h in D2O): δ 4.28 (dd, J = 11.7, 9.3 Hz, 1H), 4.09−4.01 (m, 2H), 3.84 (ddd, J = 9.2, 5.3, 1.3 Hz, 1H), 3.27 (d, J = 10.1 Hz, 1H), 2.84 (d, J = 16.9 Hz, 1H), 2.63 (d, J = 16.9 Hz, 1H) ppm; 13C{1H} NMR (150 MHz, determined by HMBC/HSQC, D2O): δ 177.3, 159.1, 158.0, 156.1, 99.3, 83.0, 62.1, 56.0, 52.0, 46.8, 38.3, 30.5 ppm; HRMS (ES+): calcd for C12H20N7O6, 358.1470 [M + H]+; found, 358.1471.

ACKNOWLEDGMENTS

We are grateful to SiteOne Therapeutics for a gift of 40 g of an intermediate compound and to the National Institutes of Health [R01 GM117263-05 (J.D.B.) and F32 GM122179 (T.A.B.)] for support of this program.

Footnotes

Supporting Information

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.joc.1c02116.

Tabulated spectral data for 11-SEA and 1H, 13C, and 2D NMR spectra (PDF)

Complete contact information is available at: https://pubs.acs.org/10.1021/acs.joc.1c02116

The authors declare the following competing financial interest(s): J. Du Bois is a cofounder and holds equity shares in SiteOne Therapeutics, Inc., a start-up company interested in developing subtype-selective modulators of sodium channels.

Contributor Information

Doris T. Y. Tang, Department of Chemistry, Stanford University, Stanford, California 94305, United States; Present Address: Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404

Jeffrey E. Merit, Department of Chemistry, Stanford University, Stanford, California 94305, United States; Present Address: Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404

T. Aaron Bedell, Department of Chemistry, Stanford University, Stanford, California 94305, United States; Present Address: Vertex Pharmaceuticals, 3215 Merryfield Row, San Diego, CA 92121..

J. Du Bois, Department of Chemistry, Stanford University, Stanford, California 94305, United States;.

REFERENCES

  • (1).(a) Durén-Riveroll L; Cembella A Guanidinium Toxins and Their Interactions with Voltage-Gated Sodium Ion Channels. Mar. Drugs 2017, 15, 303. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Thottumkara AP; Parsons WH; Du Bois J Saxitoxin. Angew. Chem. Int. Ed 2014, 53, 5760–5784. [DOI] [PubMed] [Google Scholar]; (c) Wiese M; D’Agostino PM; Mihali TK; Moffitt MC; Neilan BA Neurotoxin Alkaloids: Saxitoxin and its Analogs. Mar. Drugs 2010, 8, 2185–2211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (2).Akbar MA; Mohd Yusof NY; Tahir NI; Ahmad A; Usup G; Sahrani FK; Bunawan H Biosynthesis of Saxitoxin in Marine Dinoflagellates: An Omics Perspective. Mar. Drugs 2020, 18, 103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (3).For leading references, see:; (a) Lukowski AL; Liu J; Bridwell-Rabb J; Narayan ARH Structural basis for divergent C–H hydroxylation selectivity in two Rieske oxygenases. Nat. Commun 2020, 11, 2991. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Soeriyadi AH; Mazmouz R; Pickford R; Al-Sinawi B; Kellmann R; Pearson LA; Neilan BA Heterologous Expression of an Unusual Ketosynthase, SxtA, Leads to Production of Saxitoxin Intermediates in Escherichia coli. ChemBioChem 2020, 22, 845–849. [DOI] [PubMed] [Google Scholar]; (c) Lukowski AL; Denomme N; Hinze ME; Hall S; Isom LL; Narayan ARH Biocatalytic Detoxification of Paralytic Shellfish Toxins. ACS Chem. Biol 2019, 14, 941–948. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Tsuchiya S; Cho Y; Yoshioka R; Konoki K; Nagasawa K; Oshima Y; Yotsu-Yamashita M Synthesis and Identification of Key Biosynthetic Intermediates for the Formation of the Tricyclic Skeleton of Saxitoxin. Angew. Chem. Int. Ed 2017, 56, 5327–5331. [DOI] [PubMed] [Google Scholar]
  • (4).Arakawa O; Nishio S; Noguchi T; Shida Y; Onoue Y A new saxitoxin analogue from xanthid crab Atergatis floridus. Toxicon 1995, 33, 1577–1584. [DOI] [PubMed] [Google Scholar]
  • (5).(a) Yotsu-Yamashita M; Kim YH; Dudley SC Jr.; Choudhary G; Pfahnl A; Oshima Y; Daly JW The structure of zetekitoxin AB, a saxitoxin analog from the Panamanian golden frog Atelopus zeteki: A potent sodium-channel blocker. Proc. Natl. Acad. Sci. U.S.A 2004, 101, 4346–4351. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Brown GB; Kim YH; Küntzel H; Mosher HS; Fuhrman GJ; Fuhrman FA Chemistry and pharmacology of skin toxins from the frog Atelopus Zeteki (Atelopidtoxin: Zetekitoxin). Toxicon 1977, 15, 115–128. [DOI] [PubMed] [Google Scholar]
  • (6).(a) Pajouhesh H; Beckley JT; Delwig A; Hajare HS; Luu G; Monteleone D; Zhou X; Ligutti J; Amagasu S; Moyer BD; Yeomans DC; Du Bois J; Mulcahy JV Discovery of a selective, state-independent inhibitor of Nav1.7 by modification of guanidinium toxins. Sci. Rep 2020, 10, 14791. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Elleman AV; Devienne G; Makinson CD; Haynes AL; Huguenard JR; Du Bois J Precise spatiotemporal control of voltage-gated sodium channels by photocaged saxitoxin. Nat. Commun 2021, 12, 4171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (7).Walker JR; Merit JE; Thomas-Tran R; Tang DTY; Du Bois J Divergent Synthesis of Natural Derivatives of (+)-Saxitoxin Including 11-Saxitoxinethanoic Acid. Angew. Chem. Int. Ed 2019, 58, 1689–1693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (8).For two other reported syntheses of 11-SEA, see:; (a) Wang C; Oki M; Nishikawa T; Harada D; Yotsu-Yamashita M; Nagasawa K Total Synthesis of 11-Saxitoxinethanoic Acid and Evaluation of its Inhibitory Activity on Voltage-Gated Sodium Channels. Angew. Chem. Int. Ed 2016, 55, 11600–11603. [DOI] [PubMed] [Google Scholar]; (b) Paladugu SR; James CK; Looper RE A Direct C11 Alkylation Strategy on the Saxitoxin Core: A Synthesis of (+)-11-Saxitoxinethanoic Acid. Org. Lett 2019, 21, 7999–8002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (9).Bray BL; Mathies PH; Naef R; Solas DR; Tidwell TT; Artis DR; Muchowski JM N-(Triisopropylsilyl)pyrrole. A Progenitor “Par Excellence” of 3-Substituted Pyrroles. J. Org. Chem 1990, 55, 6317–6328. [Google Scholar]
  • (10).Stöckigt J; Antonchick AP; Wu F; Waldmann H The Pictet-Spengler Reaction in Nature and in Organic Chemistry. Angew. Chem. Int. Ed 2011, 50, 8538–8564. [DOI] [PubMed] [Google Scholar]
  • (11).(a) Lambert JB The Interaction of Silicon with Positively Charged Carbon. Tetrahedron 1990, 46, 2677–2689. [Google Scholar]; (b) Dichiarante V; Salvaneschi A; Protti S; Dondi D; Fagnoni M; Albini A The β Effect of Silicon in Phenyl Cations. J. Am. Chem. Soe 2007, 129, 15919–15926. [DOI] [PubMed] [Google Scholar]
  • (12).Garro-Helion F; Merzouk A; Guibé F Mild and Selective Palladium(0)-Catalyzed Deallylation of Allylic Amines. Allylamine and Diallylamine as Very Convenient Ammonia Equivalents for the Synthesis of Primary Amines. J. Org. Chem 1993, 58, 6109–6113. [Google Scholar]
  • (13).These transformations follow our earlier report, see:; Mulcahy JV; Walker JR; Merit JE; Whitehead A; Du Bois J Synthesis of the Paralytic Shellfish Poisons (+)-Gonyautoxin 2, (+)-Gonyautoxin 3, and (+)-11,11-Dihydroxysaxitoxin. J. Am. Chem. Soc 2016, 138, 5994–6001. [DOI] [PubMed] [Google Scholar]
  • (14).In the absence of rhodium catalyst, cyclization of pyrrole 18 proceeds in 20–25% yield.
  • (15).Rojas CM Rojas CM Molecular Rearrangements in Organic Synthesis, Ed.; John Wiley & Sons, Inc., 2016; pp 569–625. [Google Scholar]
  • (16).Use of more conventional alcohol solvents for the Evans–Mislow reaction is lower yielding and results in partial exchange of the Troc-protecting group.
  • (17).Fleming I; Dunoguès J; Smithers R The Electrophilic Substitution of Allylsilanes and Vinylsilanes. Org. React 1989, 37, 57–575. [Google Scholar]
  • (18).Le Bideau F; Gilloir F; Nilsson Y; Aubert C; Malacria M Stereocontrolled synthesis of α-triakylsilyl-β,γ-unsaturated aldehydes via palladium(0) catalysis. Synthetic usefulness. Tetrahedron 1996, 52, 7487–7510. [Google Scholar]
  • (19).(a) Brook AG Molecular rearrangements of organosilicon compounds. Acc. Chem. Res 1974, 7, 77–84. [Google Scholar]; (b) Fleming I; Lee TV The γ-Alkylation of Enones Using Silyl Dienol Ethers: The Effect of Changing the Electrophile and of Changing the Silyl Group. Tetrahedron Lett 1981, 22, 705–708. [Google Scholar]; (c) Hudrlik PF; Hudrlik AM; Kulkarni AK Elimination Reactions of α,β-Dihydroxysilanes: Stereospecific Synthesis of Silyl Enol Ethers from Vinylsilanes. J. Am. Chem. Soc 1985, 107, 4260–4264. [Google Scholar]
  • (20).Kumar D; Vemula SR; Balasubramanian N; Cook GR Indium-Mediated Stereoselective Allylation. Acc. Chem. Res 2016, 49, 2169–2178. [DOI] [PubMed] [Google Scholar]
  • (21).Blanchette MA; Choy W; Davis JT; Essenfeld AP; Masamune S; Roush WR; Sakai T Horner-Wadsworth-Emmons Reaction: Use of Lithium Chloride and an Amine for Base-Sensitive Compounds. Tetrahedron Lett 1984, 25, 2183–2186. [Google Scholar]
  • (22).(a) Janicki I; Kiełbasiński P Still-Gennari Olefination and its Application in Organic Synthesis. Adv. Synth. Catal 2020, 362, 2552–2596. [Google Scholar]; (b) Still WC; Gennari C Direct Synthesis of Z-Unsaturated Esters. A Useful Modification of the Horner-Emmons Olefination. Tetrahedron Lett 1983, 24, 4405–4408. [Google Scholar]
  • (23).The mass balance for this reaction and others involving ketone 26 is largely unaccounted for owing to the proclivity of this material to decompose under both acidic and basic conditions.
  • (24).(a) Trost BM; Rudd MT Ruthenium-Catalyzed Alkyne-Propargyl Alcohol Addition. An Asymmetric Total Synthesis of (+)-Kainic Acid. Org. Lett 2003, 5, 1467–1470. [DOI] [PubMed] [Google Scholar]; (b) Crabtree RH; Davis MW Directing Effects in Homogeneous Hydrogenation with [Ir(cod)(PCy3)(py)]PF6. J. Org. Chem 1986, 51, 2655–2661. [Google Scholar]
  • (25).(a) Lai L; Li A-N; Zhou J; Guo Y; Lin L; Chen W; Wang R Mg(OMe)2 promoted allylic isomerization of γ-hydroxy-α,β-alkenoic esters to synthesize γ-ketone esters. Org. Biomol. Chem 2017, 15, 2185–2190. [DOI] [PubMed] [Google Scholar]; (b) Di Giacomo M; Leggeri P; Azzolina O; Pirillo D; Traverso G Basic Isomerization of Some Methyl 4-Hydroxy-4-alkylbut-2-enoates. J. Chem. Res., Synop 1990, 16–17. [Google Scholar]
  • (26).Sharefkin JG; Saltzman H Iodosobenzene Diacetate. Org. Synth 1963, 43, 62. [Google Scholar]
  • (27).Aggarwal VK; Gültekin Z; Grainger RS; Adams H; Spargo PL (1R,3R)-2-Methylene-1,3-dithiolane 1,3-dioxide: a highly reactive and highly selective chiral ketene equivalent in cycloaddition reactions with a broad range of dienes. J. Chem. Soc., Perkin Trans 1 1998, 2771–2782. [Google Scholar]
  • (28).This material is commercially available and can be easily prepared, see:; Outlaw VK; Townsend CA A Practical Route to Substituted 7-Aminoindoles from Pyrrole-3-carboxyaldehydes. Org. Lett 2014, 16, 6334–6337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (29).For preparation of this reagent, see:; Kim M; Mulcahy JV; Espino CG; Du Bois J Expanding the Substrate Scope for C–H Amination Reactions: Oxidative Cyclization of Urea and Guanidine Derivatives. Org. Lett 2006, 8, 1073–1076. [DOI] [PubMed] [Google Scholar]

RESOURCES